Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for ESRRA_ESR2
Z-value: 3.67
Motif logo
Transcription factors associated with ESRRA_ESR2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ESRRA
|
ENSG00000173153.9 | estrogen related receptor alpha |
|
ESR2
|
ENSG00000140009.14 | estrogen receptor 2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ESR2 | hg19_v2_chr14_-_64761078_64761128 | 0.90 | 6.9e-08 | Click! |
| ESRRA | hg19_v2_chr11_+_64073022_64073056 | 0.50 | 2.3e-02 | Click! |
Activity profile of ESRRA_ESR2 motif
Sorted Z-values of ESRRA_ESR2 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr6_+_31916733 | 10.42 |
ENST00000483004.1
|
CFB
|
complement factor B |
| chr2_+_228678550 | 10.14 |
ENST00000409189.3
ENST00000358813.4 |
CCL20
|
chemokine (C-C motif) ligand 20 |
| chr20_+_61867235 | 9.69 |
ENST00000342412.6
ENST00000217169.3 |
BIRC7
|
baculoviral IAP repeat containing 7 |
| chr19_+_859654 | 7.92 |
ENST00000592860.1
|
CFD
|
complement factor D (adipsin) |
| chr19_+_859425 | 7.69 |
ENST00000327726.6
|
CFD
|
complement factor D (adipsin) |
| chr20_+_36974759 | 7.29 |
ENST00000217407.2
|
LBP
|
lipopolysaccharide binding protein |
| chr19_+_5914213 | 6.82 |
ENST00000222125.5
ENST00000452990.2 ENST00000588865.1 |
CAPS
|
calcyphosine |
| chr19_+_589893 | 6.46 |
ENST00000251287.2
|
HCN2
|
hyperpolarization activated cyclic nucleotide-gated potassium channel 2 |
| chr11_-_117695449 | 6.41 |
ENST00000292079.2
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
| chr7_-_95025661 | 5.92 |
ENST00000542556.1
ENST00000265627.5 ENST00000427422.1 ENST00000451904.1 |
PON1
PON3
|
paraoxonase 1 paraoxonase 3 |
| chr1_-_32827682 | 5.84 |
ENST00000432622.1
|
FAM229A
|
family with sequence similarity 229, member A |
| chr19_-_460996 | 5.72 |
ENST00000264554.6
|
SHC2
|
SHC (Src homology 2 domain containing) transforming protein 2 |
| chr11_+_313503 | 5.49 |
ENST00000528780.1
ENST00000328221.5 |
IFITM1
|
interferon induced transmembrane protein 1 |
| chr19_+_2977444 | 5.49 |
ENST00000246112.4
ENST00000453329.1 ENST00000482627.1 ENST00000452088.1 |
TLE6
|
transducin-like enhancer of split 6 (E(sp1) homolog, Drosophila) |
| chr4_-_155533787 | 5.32 |
ENST00000407946.1
ENST00000405164.1 ENST00000336098.3 ENST00000393846.2 ENST00000404648.3 ENST00000443553.1 |
FGG
|
fibrinogen gamma chain |
| chr7_-_45960850 | 5.22 |
ENST00000381083.4
ENST00000381086.5 ENST00000275521.6 |
IGFBP3
|
insulin-like growth factor binding protein 3 |
| chr3_-_48632593 | 5.22 |
ENST00000454817.1
ENST00000328333.8 |
COL7A1
|
collagen, type VII, alpha 1 |
| chr3_+_133465228 | 5.08 |
ENST00000482271.1
ENST00000264998.3 |
TF
|
transferrin |
| chr14_-_24911868 | 5.05 |
ENST00000554698.1
|
SDR39U1
|
short chain dehydrogenase/reductase family 39U, member 1 |
| chr11_+_2923499 | 4.98 |
ENST00000449793.2
|
SLC22A18
|
solute carrier family 22, member 18 |
| chr15_+_65337708 | 4.94 |
ENST00000334287.2
|
SLC51B
|
solute carrier family 51, beta subunit |
| chr14_-_23791484 | 4.89 |
ENST00000594872.1
|
AL049829.1
|
Uncharacterized protein |
| chr8_+_142402089 | 4.81 |
ENST00000521578.1
ENST00000520105.1 ENST00000523147.1 |
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3 |
| chr2_+_120189422 | 4.80 |
ENST00000306406.4
|
TMEM37
|
transmembrane protein 37 |
| chr3_-_49726104 | 4.79 |
ENST00000383728.3
ENST00000545762.1 |
MST1
|
macrophage stimulating 1 (hepatocyte growth factor-like) |
| chr19_-_58864848 | 4.76 |
ENST00000263100.3
|
A1BG
|
alpha-1-B glycoprotein |
| chr7_+_5322561 | 4.69 |
ENST00000396872.3
ENST00000444741.1 ENST00000297195.4 ENST00000406453.3 |
SLC29A4
|
solute carrier family 29 (equilibrative nucleoside transporter), member 4 |
| chr19_+_10197463 | 4.67 |
ENST00000590378.1
ENST00000397881.3 |
C19orf66
|
chromosome 19 open reading frame 66 |
| chr12_-_117537240 | 4.56 |
ENST00000392545.4
ENST00000541210.1 ENST00000335209.7 |
TESC
|
tescalcin |
| chr1_+_37947257 | 4.55 |
ENST00000471012.1
|
ZC3H12A
|
zinc finger CCCH-type containing 12A |
| chr19_+_46001697 | 4.53 |
ENST00000451287.2
ENST00000324688.4 |
PPM1N
|
protein phosphatase, Mg2+/Mn2+ dependent, 1N (putative) |
| chr19_+_50919056 | 4.41 |
ENST00000599632.1
|
CTD-2545M3.6
|
CTD-2545M3.6 |
| chr20_-_34542548 | 4.33 |
ENST00000305978.2
|
SCAND1
|
SCAN domain containing 1 |
| chr4_+_668348 | 4.30 |
ENST00000511290.1
|
MYL5
|
myosin, light chain 5, regulatory |
| chr22_-_24110063 | 4.27 |
ENST00000520222.1
ENST00000401675.3 |
CHCHD10
|
coiled-coil-helix-coiled-coil-helix domain containing 10 |
| chr19_+_1041212 | 4.27 |
ENST00000433129.1
|
ABCA7
|
ATP-binding cassette, sub-family A (ABC1), member 7 |
| chr6_+_29691198 | 4.26 |
ENST00000440587.2
ENST00000434407.2 |
HLA-F
|
major histocompatibility complex, class I, F |
| chrX_-_151938171 | 4.23 |
ENST00000393902.3
ENST00000417212.1 ENST00000370278.3 |
MAGEA3
|
melanoma antigen family A, 3 |
| chr22_-_42526802 | 4.20 |
ENST00000359033.4
ENST00000389970.3 ENST00000360608.5 |
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6 |
| chr16_-_2581409 | 4.18 |
ENST00000567119.1
ENST00000565480.1 ENST00000382350.1 |
CEMP1
|
cementum protein 1 |
| chr22_+_24577183 | 4.16 |
ENST00000358321.3
|
SUSD2
|
sushi domain containing 2 |
| chr16_+_691792 | 4.15 |
ENST00000307650.4
|
FAM195A
|
family with sequence similarity 195, member A |
| chr22_-_22901636 | 4.13 |
ENST00000406503.1
ENST00000439106.1 ENST00000402697.1 ENST00000543184.1 ENST00000398743.2 |
PRAME
|
preferentially expressed antigen in melanoma |
| chr15_-_31523036 | 4.10 |
ENST00000559094.1
ENST00000558388.2 |
RP11-16E12.2
|
RP11-16E12.2 |
| chr20_-_62203808 | 4.06 |
ENST00000467148.1
|
HELZ2
|
helicase with zinc finger 2, transcriptional coactivator |
| chr15_-_31521567 | 4.05 |
ENST00000560812.1
ENST00000559853.1 ENST00000558109.1 |
RP11-16E12.2
|
RP11-16E12.2 |
| chr17_-_26697304 | 4.00 |
ENST00000536498.1
|
VTN
|
vitronectin |
| chr19_+_45251804 | 3.97 |
ENST00000164227.5
|
BCL3
|
B-cell CLL/lymphoma 3 |
| chr20_+_4152356 | 3.93 |
ENST00000379460.2
|
SMOX
|
spermine oxidase |
| chr1_-_151345159 | 3.92 |
ENST00000458566.1
ENST00000447402.3 ENST00000426705.2 ENST00000435071.1 ENST00000368868.5 |
SELENBP1
|
selenium binding protein 1 |
| chr12_+_112204691 | 3.91 |
ENST00000416293.3
ENST00000261733.2 |
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial) |
| chr6_-_30080876 | 3.90 |
ENST00000376734.3
|
TRIM31
|
tripartite motif containing 31 |
| chr2_+_233734994 | 3.90 |
ENST00000331342.2
|
C2orf82
|
chromosome 2 open reading frame 82 |
| chr11_+_1244288 | 3.85 |
ENST00000529681.1
ENST00000447027.1 |
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming |
| chr13_+_113760098 | 3.84 |
ENST00000346342.3
ENST00000541084.1 ENST00000375581.3 |
F7
|
coagulation factor VII (serum prothrombin conversion accelerator) |
| chr9_+_5231413 | 3.84 |
ENST00000239316.4
|
INSL4
|
insulin-like 4 (placenta) |
| chr9_-_35815013 | 3.84 |
ENST00000259667.5
|
HINT2
|
histidine triad nucleotide binding protein 2 |
| chr19_+_10196981 | 3.80 |
ENST00000591813.1
|
C19orf66
|
chromosome 19 open reading frame 66 |
| chr2_+_198365122 | 3.79 |
ENST00000604458.1
|
HSPE1-MOB4
|
HSPE1-MOB4 readthrough |
| chr12_+_6494285 | 3.79 |
ENST00000541102.1
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3) |
| chr22_+_23248512 | 3.79 |
ENST00000390325.2
|
IGLC3
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker) |
| chr17_+_60758814 | 3.79 |
ENST00000579432.1
ENST00000446119.2 |
MRC2
|
mannose receptor, C type 2 |
| chr16_-_67970990 | 3.79 |
ENST00000358514.4
|
PSMB10
|
proteasome (prosome, macropain) subunit, beta type, 10 |
| chr12_-_54779511 | 3.78 |
ENST00000551109.1
ENST00000546970.1 |
ZNF385A
|
zinc finger protein 385A |
| chr12_+_52445191 | 3.78 |
ENST00000243050.1
ENST00000394825.1 ENST00000550763.1 ENST00000394824.2 ENST00000548232.1 ENST00000562373.1 |
NR4A1
|
nuclear receptor subfamily 4, group A, member 1 |
| chr6_-_30080863 | 3.78 |
ENST00000540829.1
|
TRIM31
|
tripartite motif containing 31 |
| chr14_-_23288930 | 3.70 |
ENST00000554517.1
ENST00000285850.7 ENST00000397529.2 ENST00000555702.1 |
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
| chr14_-_24911448 | 3.66 |
ENST00000555355.1
ENST00000553343.1 ENST00000556523.1 ENST00000556249.1 ENST00000538105.2 ENST00000555225.1 |
SDR39U1
|
short chain dehydrogenase/reductase family 39U, member 1 |
| chr10_+_104178946 | 3.66 |
ENST00000432590.1
|
FBXL15
|
F-box and leucine-rich repeat protein 15 |
| chr14_+_103573853 | 3.66 |
ENST00000560304.1
|
EXOC3L4
|
exocyst complex component 3-like 4 |
| chr17_+_78075361 | 3.65 |
ENST00000577106.1
ENST00000390015.3 |
GAA
|
glucosidase, alpha; acid |
| chr17_+_78075498 | 3.61 |
ENST00000302262.3
|
GAA
|
glucosidase, alpha; acid |
| chr11_+_57308979 | 3.60 |
ENST00000457912.1
|
SMTNL1
|
smoothelin-like 1 |
| chr22_+_24999114 | 3.59 |
ENST00000412658.1
ENST00000445029.1 ENST00000419133.1 ENST00000400382.1 ENST00000438643.2 ENST00000452551.1 ENST00000400383.1 ENST00000412898.1 ENST00000400380.1 ENST00000455483.1 ENST00000430289.1 |
GGT1
|
gamma-glutamyltransferase 1 |
| chr1_+_1217489 | 3.56 |
ENST00000325425.8
ENST00000400928.3 |
SCNN1D
|
sodium channel, non-voltage-gated 1, delta subunit |
| chr12_+_58013693 | 3.53 |
ENST00000320442.4
ENST00000379218.2 |
SLC26A10
|
solute carrier family 26, member 10 |
| chr20_-_23731893 | 3.53 |
ENST00000398402.1
|
CST1
|
cystatin SN |
| chr17_+_4675175 | 3.52 |
ENST00000270560.3
|
TM4SF5
|
transmembrane 4 L six family member 5 |
| chr14_-_24911971 | 3.51 |
ENST00000555365.1
ENST00000399395.3 |
SDR39U1
|
short chain dehydrogenase/reductase family 39U, member 1 |
| chr2_+_120187465 | 3.49 |
ENST00000409826.1
ENST00000417645.1 |
TMEM37
|
transmembrane protein 37 |
| chr17_-_7082861 | 3.48 |
ENST00000269299.3
|
ASGR1
|
asialoglycoprotein receptor 1 |
| chr5_-_126409159 | 3.48 |
ENST00000607731.1
ENST00000535381.1 ENST00000296662.5 ENST00000509733.3 |
C5orf63
|
chromosome 5 open reading frame 63 |
| chr1_+_222988406 | 3.48 |
ENST00000448808.1
ENST00000457636.1 ENST00000439440.1 |
RP11-452F19.3
|
RP11-452F19.3 |
| chr19_+_45971246 | 3.48 |
ENST00000585836.1
ENST00000417353.2 ENST00000353609.3 ENST00000591858.1 ENST00000443841.2 ENST00000590335.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
| chr2_+_219264466 | 3.48 |
ENST00000273062.2
|
CTDSP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 |
| chr11_+_67798363 | 3.45 |
ENST00000525628.1
|
NDUFS8
|
NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase) |
| chr19_+_36157715 | 3.45 |
ENST00000379013.2
ENST00000222275.2 |
UPK1A
|
uroplakin 1A |
| chr22_-_50970506 | 3.40 |
ENST00000428989.2
ENST00000403326.1 |
ODF3B
|
outer dense fiber of sperm tails 3B |
| chr5_-_176981417 | 3.40 |
ENST00000514747.1
ENST00000443375.2 ENST00000329540.5 |
FAM193B
|
family with sequence similarity 193, member B |
| chr2_+_169658928 | 3.38 |
ENST00000317647.7
ENST00000445023.2 |
NOSTRIN
|
nitric oxide synthase trafficking |
| chr19_+_2249308 | 3.38 |
ENST00000592877.1
ENST00000221496.4 |
AMH
|
anti-Mullerian hormone |
| chr3_-_58523010 | 3.37 |
ENST00000459701.2
ENST00000302819.5 |
ACOX2
|
acyl-CoA oxidase 2, branched chain |
| chr7_-_73038822 | 3.37 |
ENST00000414749.2
ENST00000429400.2 ENST00000434326.1 |
MLXIPL
|
MLX interacting protein-like |
| chr9_-_116840728 | 3.30 |
ENST00000265132.3
|
AMBP
|
alpha-1-microglobulin/bikunin precursor |
| chr12_+_120502441 | 3.28 |
ENST00000446727.2
|
CCDC64
|
coiled-coil domain containing 64 |
| chr22_-_22901477 | 3.27 |
ENST00000420709.1
ENST00000398741.1 ENST00000405655.3 |
PRAME
|
preferentially expressed antigen in melanoma |
| chr19_+_11455900 | 3.26 |
ENST00000588790.1
|
CCDC159
|
coiled-coil domain containing 159 |
| chr19_-_6690723 | 3.26 |
ENST00000601008.1
|
C3
|
complement component 3 |
| chr22_-_24641027 | 3.25 |
ENST00000398292.3
ENST00000263112.7 ENST00000418439.2 ENST00000424217.1 ENST00000327365.4 |
GGT5
|
gamma-glutamyltransferase 5 |
| chr19_+_49055332 | 3.25 |
ENST00000201586.2
|
SULT2B1
|
sulfotransferase family, cytosolic, 2B, member 1 |
| chr2_+_169659121 | 3.23 |
ENST00000397206.2
ENST00000397209.2 ENST00000421711.2 |
NOSTRIN
|
nitric oxide synthase trafficking |
| chr19_-_43032532 | 3.22 |
ENST00000403461.1
ENST00000352591.5 ENST00000358394.3 ENST00000403444.3 ENST00000308072.4 ENST00000599389.1 ENST00000351134.3 ENST00000161559.6 |
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
| chr11_-_63993601 | 3.22 |
ENST00000545812.1
ENST00000394547.3 ENST00000317459.6 |
TRPT1
|
tRNA phosphotransferase 1 |
| chr3_+_149191723 | 3.21 |
ENST00000305354.4
|
TM4SF4
|
transmembrane 4 L six family member 4 |
| chrX_+_70364667 | 3.21 |
ENST00000536169.1
ENST00000395855.2 ENST00000374051.3 ENST00000358741.3 |
NLGN3
|
neuroligin 3 |
| chr7_-_17500294 | 3.20 |
ENST00000439046.1
|
AC019117.2
|
AC019117.2 |
| chr5_-_138718973 | 3.19 |
ENST00000353963.3
ENST00000348729.3 |
SLC23A1
|
solute carrier family 23 (ascorbic acid transporter), member 1 |
| chr7_+_99971068 | 3.19 |
ENST00000198536.2
ENST00000453419.1 |
PILRA
|
paired immunoglobin-like type 2 receptor alpha |
| chrX_-_48693955 | 3.18 |
ENST00000218230.5
|
PCSK1N
|
proprotein convertase subtilisin/kexin type 1 inhibitor |
| chr4_+_980785 | 3.18 |
ENST00000247933.4
ENST00000453894.1 |
IDUA
|
iduronidase, alpha-L- |
| chr16_-_2827128 | 3.17 |
ENST00000494946.2
ENST00000409477.1 ENST00000572954.1 ENST00000262306.7 ENST00000409906.4 |
TCEB2
|
transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) |
| chr19_-_41256207 | 3.17 |
ENST00000598485.2
ENST00000470681.1 ENST00000339153.3 ENST00000598729.1 |
C19orf54
|
chromosome 19 open reading frame 54 |
| chr19_-_49371711 | 3.16 |
ENST00000355496.5
ENST00000263265.6 |
PLEKHA4
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4 |
| chr9_+_130965651 | 3.15 |
ENST00000475805.1
ENST00000341179.7 ENST00000372923.3 |
DNM1
|
dynamin 1 |
| chr12_-_121476959 | 3.15 |
ENST00000339275.5
|
OASL
|
2'-5'-oligoadenylate synthetase-like |
| chr11_-_17555421 | 3.14 |
ENST00000526181.1
|
USH1C
|
Usher syndrome 1C (autosomal recessive, severe) |
| chr4_-_140216948 | 3.14 |
ENST00000265500.4
|
NDUFC1
|
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa |
| chr2_+_241544834 | 3.13 |
ENST00000319838.5
ENST00000403859.1 ENST00000438013.2 |
GPR35
|
G protein-coupled receptor 35 |
| chr19_+_55738587 | 3.13 |
ENST00000598855.1
|
AC010327.2
|
Uncharacterized protein; cDNA FLJ45856 fis, clone OCBBF2025631 |
| chr12_+_57916466 | 3.12 |
ENST00000355673.3
|
MBD6
|
methyl-CpG binding domain protein 6 |
| chr9_+_130965677 | 3.10 |
ENST00000393594.3
ENST00000486160.1 |
DNM1
|
dynamin 1 |
| chr10_+_7745303 | 3.10 |
ENST00000429820.1
ENST00000379587.4 |
ITIH2
|
inter-alpha-trypsin inhibitor heavy chain 2 |
| chr8_-_145752390 | 3.07 |
ENST00000529415.2
ENST00000533758.1 |
LRRC24
|
leucine rich repeat containing 24 |
| chr22_+_23243156 | 3.06 |
ENST00000390323.2
|
IGLC2
|
immunoglobulin lambda constant 2 (Kern-Oz- marker) |
| chr19_+_56152262 | 3.05 |
ENST00000325333.5
ENST00000590190.1 |
ZNF580
|
zinc finger protein 580 |
| chrX_+_106163626 | 3.04 |
ENST00000336803.1
|
CLDN2
|
claudin 2 |
| chr16_-_4401258 | 3.03 |
ENST00000577031.1
|
PAM16
|
presequence translocase-associated motor 16 homolog (S. cerevisiae) |
| chr1_-_91317072 | 3.03 |
ENST00000435649.2
ENST00000443802.1 |
RP4-665J23.1
|
RP4-665J23.1 |
| chr8_+_145734433 | 3.03 |
ENST00000301327.4
|
MFSD3
|
major facilitator superfamily domain containing 3 |
| chr11_+_65190245 | 3.03 |
ENST00000499732.1
ENST00000501122.2 ENST00000601801.1 |
NEAT1
|
nuclear paraspeckle assembly transcript 1 (non-protein coding) |
| chr1_-_230850043 | 3.02 |
ENST00000366667.4
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
| chr14_-_102026643 | 3.02 |
ENST00000555882.1
ENST00000554441.1 ENST00000553729.1 ENST00000557109.1 ENST00000557532.1 ENST00000554694.1 ENST00000554735.1 ENST00000555174.1 ENST00000557661.1 |
DIO3OS
|
DIO3 opposite strand/antisense RNA (head to head) |
| chr12_+_121163538 | 3.02 |
ENST00000242592.4
|
ACADS
|
acyl-CoA dehydrogenase, C-2 to C-3 short chain |
| chr9_-_34665983 | 3.02 |
ENST00000416454.1
ENST00000544078.2 ENST00000421828.2 ENST00000423809.1 |
RP11-195F19.5
|
HCG2040265, isoform CRA_a; Uncharacterized protein; cDNA FLJ50015 |
| chr14_+_101299520 | 3.02 |
ENST00000455531.1
|
MEG3
|
maternally expressed 3 (non-protein coding) |
| chr11_+_114128522 | 3.01 |
ENST00000535401.1
|
NNMT
|
nicotinamide N-methyltransferase |
| chr19_-_1605424 | 3.01 |
ENST00000589880.1
ENST00000585671.1 ENST00000591899.3 |
UQCR11
|
ubiquinol-cytochrome c reductase, complex III subunit XI |
| chr6_-_43027105 | 3.00 |
ENST00000230413.5
ENST00000487429.1 ENST00000489623.1 ENST00000468957.1 |
MRPL2
|
mitochondrial ribosomal protein L2 |
| chr6_-_43197189 | 2.99 |
ENST00000509253.1
ENST00000393987.2 ENST00000230431.6 |
DNPH1
|
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
| chr12_-_121477039 | 2.98 |
ENST00000257570.5
|
OASL
|
2'-5'-oligoadenylate synthetase-like |
| chr11_+_2923423 | 2.98 |
ENST00000312221.5
|
SLC22A18
|
solute carrier family 22, member 18 |
| chr19_-_39402798 | 2.98 |
ENST00000571838.1
|
CTC-360G5.1
|
coiled-coil glutamate-rich protein 2 |
| chr19_-_42192189 | 2.97 |
ENST00000401731.1
ENST00000338196.4 ENST00000006724.3 |
CEACAM7
|
carcinoembryonic antigen-related cell adhesion molecule 7 |
| chr15_-_41120896 | 2.96 |
ENST00000299174.5
ENST00000427255.2 |
PPP1R14D
|
protein phosphatase 1, regulatory (inhibitor) subunit 14D |
| chr11_+_67798114 | 2.95 |
ENST00000453471.2
ENST00000528492.1 ENST00000526339.1 ENST00000525419.1 |
NDUFS8
|
NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase) |
| chr16_-_89785777 | 2.95 |
ENST00000561976.1
|
VPS9D1
|
VPS9 domain containing 1 |
| chr17_+_32582293 | 2.95 |
ENST00000580907.1
ENST00000225831.4 |
CCL2
|
chemokine (C-C motif) ligand 2 |
| chrX_+_151867214 | 2.93 |
ENST00000329342.5
ENST00000412733.1 ENST00000457643.1 |
MAGEA6
|
melanoma antigen family A, 6 |
| chr7_-_100287071 | 2.93 |
ENST00000275732.5
|
GIGYF1
|
GRB10 interacting GYF protein 1 |
| chr17_-_19265855 | 2.92 |
ENST00000440841.1
ENST00000395615.1 ENST00000461069.2 |
B9D1
|
B9 protein domain 1 |
| chr17_-_79167828 | 2.92 |
ENST00000570817.1
|
AZI1
|
5-azacytidine induced 1 |
| chr12_+_121416340 | 2.90 |
ENST00000257555.6
ENST00000400024.2 |
HNF1A
|
HNF1 homeobox A |
| chr16_+_2076869 | 2.90 |
ENST00000424542.2
ENST00000432365.2 |
SLC9A3R2
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 |
| chr19_+_6372444 | 2.90 |
ENST00000245812.3
|
ALKBH7
|
alkB, alkylation repair homolog 7 (E. coli) |
| chr11_+_66059339 | 2.89 |
ENST00000327259.4
|
TMEM151A
|
transmembrane protein 151A |
| chr11_+_60691924 | 2.88 |
ENST00000544065.1
ENST00000453848.2 ENST00000005286.4 |
TMEM132A
|
transmembrane protein 132A |
| chr19_-_12146483 | 2.88 |
ENST00000455504.2
ENST00000547560.1 ENST00000552904.1 ENST00000419886.2 ENST00000550507.1 ENST00000344980.6 ENST00000550745.1 ENST00000411841.1 |
ZNF433
|
zinc finger protein 433 |
| chr2_+_105471969 | 2.87 |
ENST00000361360.2
|
POU3F3
|
POU class 3 homeobox 3 |
| chr15_-_74501360 | 2.86 |
ENST00000323940.5
|
STRA6
|
stimulated by retinoic acid 6 |
| chr15_-_74504560 | 2.86 |
ENST00000449139.2
|
STRA6
|
stimulated by retinoic acid 6 |
| chr19_-_13947099 | 2.86 |
ENST00000587762.1
|
MIR24-2
|
microRNA 24-2 |
| chr1_+_222988464 | 2.86 |
ENST00000420335.1
|
RP11-452F19.3
|
RP11-452F19.3 |
| chr9_-_140115775 | 2.85 |
ENST00000391553.1
ENST00000392827.1 |
RNF208
|
ring finger protein 208 |
| chr11_+_126276070 | 2.85 |
ENST00000449406.2
ENST00000532243.1 |
ST3GAL4
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
| chr19_-_39322497 | 2.85 |
ENST00000221418.4
|
ECH1
|
enoyl CoA hydratase 1, peroxisomal |
| chr7_+_45928079 | 2.84 |
ENST00000468955.1
|
IGFBP1
|
insulin-like growth factor binding protein 1 |
| chr17_-_66287257 | 2.82 |
ENST00000327268.4
|
SLC16A6
|
solute carrier family 16, member 6 |
| chr22_-_36013368 | 2.82 |
ENST00000442617.1
ENST00000397326.2 ENST00000397328.1 ENST00000451685.1 |
MB
|
myoglobin |
| chr10_-_76995769 | 2.82 |
ENST00000372538.3
|
COMTD1
|
catechol-O-methyltransferase domain containing 1 |
| chr16_+_28996416 | 2.81 |
ENST00000395456.2
ENST00000454369.2 |
LAT
|
linker for activation of T cells |
| chr1_+_32827759 | 2.80 |
ENST00000373534.3
|
TSSK3
|
testis-specific serine kinase 3 |
| chr14_+_24630465 | 2.79 |
ENST00000557894.1
ENST00000559284.1 ENST00000560275.1 |
IRF9
|
interferon regulatory factor 9 |
| chr14_-_94857004 | 2.78 |
ENST00000557492.1
ENST00000448921.1 ENST00000437397.1 ENST00000355814.4 ENST00000393088.4 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
| chr16_+_84209738 | 2.78 |
ENST00000564928.1
|
DNAAF1
|
dynein, axonemal, assembly factor 1 |
| chr10_-_76995675 | 2.77 |
ENST00000469299.1
|
COMTD1
|
catechol-O-methyltransferase domain containing 1 |
| chr1_+_159750720 | 2.77 |
ENST00000368109.1
ENST00000368108.3 |
DUSP23
|
dual specificity phosphatase 23 |
| chr17_+_73629500 | 2.77 |
ENST00000375215.3
|
SMIM5
|
small integral membrane protein 5 |
| chr22_+_30821732 | 2.76 |
ENST00000355143.4
|
MTFP1
|
mitochondrial fission process 1 |
| chr22_-_30960876 | 2.75 |
ENST00000401975.1
ENST00000428682.1 ENST00000423299.1 |
GAL3ST1
|
galactose-3-O-sulfotransferase 1 |
| chr2_-_27603582 | 2.74 |
ENST00000323703.6
ENST00000436006.1 |
ZNF513
|
zinc finger protein 513 |
| chr11_-_615570 | 2.73 |
ENST00000525445.1
ENST00000348655.6 ENST00000397566.1 |
IRF7
|
interferon regulatory factor 7 |
| chr22_+_29279552 | 2.72 |
ENST00000544604.2
|
ZNRF3
|
zinc and ring finger 3 |
| chr22_+_35776828 | 2.71 |
ENST00000216117.8
|
HMOX1
|
heme oxygenase (decycling) 1 |
| chr9_-_75567962 | 2.71 |
ENST00000297785.3
ENST00000376939.1 |
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1 |
| chrX_+_153639856 | 2.71 |
ENST00000426834.1
ENST00000369790.4 ENST00000454722.1 ENST00000350743.4 ENST00000299328.5 ENST00000351413.4 |
TAZ
|
tafazzin |
| chr20_+_57875457 | 2.71 |
ENST00000337938.2
ENST00000311585.7 ENST00000371028.2 |
EDN3
|
endothelin 3 |
| chr1_+_32666188 | 2.71 |
ENST00000421922.2
|
CCDC28B
|
coiled-coil domain containing 28B |
| chr22_+_21996549 | 2.70 |
ENST00000248958.4
|
SDF2L1
|
stromal cell-derived factor 2-like 1 |
| chr10_+_7745232 | 2.70 |
ENST00000358415.4
|
ITIH2
|
inter-alpha-trypsin inhibitor heavy chain 2 |
| chr16_-_4401284 | 2.70 |
ENST00000318059.3
|
PAM16
|
presequence translocase-associated motor 16 homolog (S. cerevisiae) |
| chr7_-_150777874 | 2.69 |
ENST00000540185.1
|
FASTK
|
Fas-activated serine/threonine kinase |
| chr14_+_24641062 | 2.69 |
ENST00000311457.3
ENST00000557806.1 ENST00000559919.1 |
REC8
|
REC8 meiotic recombination protein |
| chr5_-_90610200 | 2.68 |
ENST00000511918.1
ENST00000513626.1 ENST00000607854.1 |
LUCAT1
RP11-213H15.4
|
lung cancer associated transcript 1 (non-protein coding) RP11-213H15.4 |
| chr16_-_88717482 | 2.68 |
ENST00000261623.3
|
CYBA
|
cytochrome b-245, alpha polypeptide |
| chr9_+_139690784 | 2.68 |
ENST00000338005.6
|
KIAA1984
|
coiled-coil domain containing 183 |
| chr7_+_148982396 | 2.67 |
ENST00000418158.2
|
ZNF783
|
zinc finger family member 783 |
| chr22_-_30956746 | 2.67 |
ENST00000437282.1
ENST00000447224.1 ENST00000427899.1 ENST00000406955.1 ENST00000452827.1 |
GAL3ST1
|
galactose-3-O-sulfotransferase 1 |
| chr19_-_45663408 | 2.66 |
ENST00000317951.4
|
NKPD1
|
NTPase, KAP family P-loop domain containing 1 |
| chr12_-_8088871 | 2.66 |
ENST00000075120.7
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3 |
| chr17_-_34207295 | 2.65 |
ENST00000463941.1
ENST00000293272.3 |
CCL5
|
chemokine (C-C motif) ligand 5 |
Network of associatons between targets according to the STRING database.
First level regulatory network of ESRRA_ESR2
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.8 | 11.3 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 2.6 | 7.9 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
| 2.5 | 7.5 | GO:0043181 | vacuolar sequestering(GO:0043181) |
| 2.1 | 6.2 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 1.9 | 5.7 | GO:1901076 | positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 1.8 | 5.4 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 1.8 | 5.4 | GO:0035623 | renal glucose absorption(GO:0035623) |
| 1.8 | 10.5 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 1.6 | 6.5 | GO:0090346 | cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 1.6 | 33.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 1.6 | 6.3 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 1.5 | 4.6 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 1.5 | 4.5 | GO:2000627 | regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
| 1.5 | 4.5 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
| 1.5 | 1.5 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 1.4 | 5.6 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 1.3 | 12.0 | GO:0046618 | drug export(GO:0046618) |
| 1.3 | 6.6 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 1.3 | 6.6 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 1.3 | 6.5 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 1.3 | 6.3 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 1.3 | 3.8 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 1.3 | 3.8 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 1.2 | 6.2 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
| 1.2 | 3.5 | GO:2000397 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 1.1 | 3.4 | GO:0043317 | regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
| 1.1 | 3.4 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 1.1 | 1.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) transcription initiation from mitochondrial promoter(GO:0006391) |
| 1.1 | 1.1 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
| 1.1 | 7.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 1.1 | 4.4 | GO:0006788 | heme oxidation(GO:0006788) |
| 1.1 | 3.3 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 1.1 | 4.4 | GO:1905225 | response to thyrotropin-releasing hormone(GO:1905225) |
| 1.1 | 3.2 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 1.1 | 7.5 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 1.1 | 5.3 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 1.0 | 5.2 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
| 1.0 | 3.1 | GO:1903947 | regulation of heart looping(GO:1901207) positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
| 1.0 | 1.0 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
| 1.0 | 10.2 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 1.0 | 4.1 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 1.0 | 5.0 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 1.0 | 2.9 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 1.0 | 1.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 1.0 | 2.9 | GO:0090381 | regulation of heart induction(GO:0090381) regulation of heart induction by canonical Wnt signaling pathway(GO:0100012) |
| 1.0 | 1.0 | GO:2000866 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 1.0 | 6.7 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 1.0 | 4.8 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.9 | 3.7 | GO:0090301 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.9 | 5.6 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.9 | 18.4 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.9 | 3.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.9 | 2.6 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
| 0.9 | 1.7 | GO:1902003 | beta-amyloid formation(GO:0034205) regulation of beta-amyloid formation(GO:1902003) |
| 0.8 | 0.8 | GO:0009447 | putrescine catabolic process(GO:0009447) polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.8 | 3.3 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.8 | 6.5 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.8 | 3.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.8 | 4.0 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.8 | 2.4 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.8 | 2.3 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 0.8 | 1.6 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.8 | 5.4 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
| 0.8 | 13.8 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.8 | 3.8 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.8 | 3.8 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.8 | 6.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.8 | 3.0 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.7 | 3.0 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.7 | 2.2 | GO:0003168 | Purkinje myocyte differentiation(GO:0003168) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 0.7 | 6.5 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.7 | 0.7 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
| 0.7 | 2.2 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
| 0.7 | 6.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.7 | 2.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.7 | 0.7 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 0.7 | 1.4 | GO:0002086 | diaphragm contraction(GO:0002086) |
| 0.7 | 0.7 | GO:0008272 | sulfate transport(GO:0008272) |
| 0.7 | 4.9 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 0.7 | 2.8 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.7 | 3.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.7 | 0.7 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.7 | 8.3 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.7 | 3.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.7 | 2.1 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) positive regulation of fibrinolysis(GO:0051919) |
| 0.7 | 6.2 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.7 | 2.0 | GO:0009080 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.7 | 2.0 | GO:0000494 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.7 | 5.4 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.7 | 4.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.7 | 2.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.7 | 2.6 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.7 | 2.0 | GO:0072039 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) negative regulation of somatic stem cell population maintenance(GO:1904673) |
| 0.6 | 1.9 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.6 | 8.4 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.6 | 3.8 | GO:0072240 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 0.6 | 1.3 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 0.6 | 3.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.6 | 3.8 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.6 | 1.9 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.6 | 0.6 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.6 | 1.2 | GO:0002266 | follicular dendritic cell activation(GO:0002266) |
| 0.6 | 18.3 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.6 | 3.0 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.6 | 4.2 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.6 | 9.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.6 | 1.2 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 0.6 | 4.8 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.6 | 1.2 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.6 | 0.6 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) |
| 0.6 | 14.0 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.6 | 2.9 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.6 | 3.4 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.6 | 3.4 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 0.6 | 2.9 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.6 | 4.6 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
| 0.6 | 0.6 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.6 | 0.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
| 0.6 | 1.7 | GO:0046081 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.6 | 2.2 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.6 | 2.2 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.6 | 3.3 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.5 | 1.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
| 0.5 | 1.6 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.5 | 3.2 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.5 | 0.5 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.5 | 16.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.5 | 0.5 | GO:0044246 | regulation of collagen metabolic process(GO:0010712) regulation of multicellular organismal metabolic process(GO:0044246) |
| 0.5 | 4.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.5 | 2.6 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) |
| 0.5 | 5.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.5 | 2.6 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.5 | 10.0 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.5 | 1.5 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.5 | 2.1 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
| 0.5 | 8.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.5 | 1.5 | GO:0090427 | activation of meiosis(GO:0090427) |
| 0.5 | 3.0 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.5 | 4.0 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.5 | 1.0 | GO:0071156 | regulation of cell cycle arrest(GO:0071156) |
| 0.5 | 2.5 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
| 0.5 | 10.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.5 | 1.5 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
| 0.5 | 3.5 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
| 0.5 | 3.5 | GO:1901569 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.5 | 5.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.5 | 6.5 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.5 | 9.9 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.5 | 1.5 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.5 | 4.5 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
| 0.5 | 1.5 | GO:0021569 | rhombomere 3 development(GO:0021569) |
| 0.5 | 1.5 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.5 | 2.4 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.5 | 1.5 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.5 | 1.5 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.5 | 1.0 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
| 0.5 | 0.5 | GO:0072003 | kidney rudiment formation(GO:0072003) |
| 0.5 | 2.4 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.5 | 1.9 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.5 | 3.4 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 0.5 | 2.9 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.5 | 2.4 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.5 | 1.4 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.5 | 8.1 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.5 | 2.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.5 | 1.4 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.5 | 3.8 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.5 | 4.7 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.5 | 0.5 | GO:0035106 | operant conditioning(GO:0035106) |
| 0.5 | 1.4 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.5 | 1.4 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
| 0.5 | 7.0 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 0.5 | 0.5 | GO:0038066 | p38MAPK cascade(GO:0038066) |
| 0.5 | 0.9 | GO:0048806 | genitalia development(GO:0048806) |
| 0.5 | 2.7 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.5 | 2.3 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.5 | 0.9 | GO:0003285 | septum secundum development(GO:0003285) |
| 0.5 | 1.4 | GO:0052553 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.5 | 0.5 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.5 | 0.9 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.4 | 1.3 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.4 | 0.4 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 0.4 | 1.3 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.4 | 3.1 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
| 0.4 | 8.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.4 | 1.3 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.4 | 2.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.4 | 2.2 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.4 | 0.4 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
| 0.4 | 0.4 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 0.4 | 0.9 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.4 | 0.4 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.4 | 3.9 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.4 | 2.2 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 0.4 | 1.7 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.4 | 6.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.4 | 3.4 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.4 | 10.3 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.4 | 0.4 | GO:0015813 | acidic amino acid transport(GO:0015800) L-glutamate transport(GO:0015813) |
| 0.4 | 2.9 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.4 | 0.4 | GO:0045617 | negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.4 | 2.1 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
| 0.4 | 2.1 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
| 0.4 | 0.8 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.4 | 1.6 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.4 | 3.7 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.4 | 2.9 | GO:0060356 | leucine import(GO:0060356) |
| 0.4 | 4.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.4 | 3.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.4 | 3.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.4 | 2.0 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
| 0.4 | 0.4 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
| 0.4 | 1.2 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 0.4 | 2.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.4 | 1.6 | GO:0048691 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.4 | 0.8 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.4 | 8.7 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.4 | 2.8 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 0.4 | 0.8 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.4 | 1.6 | GO:0036034 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.4 | 1.6 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.4 | 0.8 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
| 0.4 | 4.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.4 | 2.0 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.4 | 1.6 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.4 | 1.9 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
| 0.4 | 3.5 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
| 0.4 | 7.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.4 | 1.9 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
| 0.4 | 0.8 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
| 0.4 | 1.2 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.4 | 0.8 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.4 | 2.3 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.4 | 1.9 | GO:0006203 | dGTP catabolic process(GO:0006203) |
| 0.4 | 4.1 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.4 | 2.6 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 0.4 | 0.4 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.4 | 1.9 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.4 | 4.1 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
| 0.4 | 1.5 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.4 | 0.7 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
| 0.4 | 2.2 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.4 | 1.5 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.4 | 3.3 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.4 | 0.4 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.4 | 0.7 | GO:0003192 | mitral valve formation(GO:0003192) |
| 0.4 | 1.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.4 | 4.4 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.4 | 28.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.4 | 1.1 | GO:0042377 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 0.4 | 1.4 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
| 0.4 | 0.4 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.4 | 15.4 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.4 | 4.3 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.4 | 1.4 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
| 0.4 | 2.5 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 0.4 | 0.7 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.4 | 0.7 | GO:0043144 | snoRNA processing(GO:0043144) |
| 0.4 | 0.4 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.4 | 0.7 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) sodium ion homeostasis(GO:0055078) |
| 0.4 | 1.1 | GO:0006147 | guanine catabolic process(GO:0006147) |
| 0.3 | 1.7 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
| 0.3 | 1.4 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.3 | 2.1 | GO:0009111 | vitamin catabolic process(GO:0009111) |
| 0.3 | 0.7 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.3 | 1.0 | GO:0030070 | insulin processing(GO:0030070) |
| 0.3 | 1.4 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.3 | 1.3 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
| 0.3 | 1.7 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.3 | 1.3 | GO:0001757 | somite specification(GO:0001757) |
| 0.3 | 0.3 | GO:0060928 | atrioventricular node development(GO:0003162) cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
| 0.3 | 0.7 | GO:1902110 | positive regulation of mitochondrial membrane permeability(GO:0035794) positive regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902110) mitochondrial outer membrane permeabilization involved in programmed cell death(GO:1902686) |
| 0.3 | 0.7 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.3 | 0.3 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.3 | 2.0 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.3 | 1.3 | GO:0051552 | flavone metabolic process(GO:0051552) |
| 0.3 | 1.0 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 0.3 | 1.0 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.3 | 1.6 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
| 0.3 | 1.6 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.3 | 2.3 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
| 0.3 | 4.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.3 | 1.0 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.3 | 1.0 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 0.3 | 18.7 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.3 | 0.6 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.3 | 0.6 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.3 | 0.9 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.3 | 7.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.3 | 2.2 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.3 | 2.2 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.3 | 0.9 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.3 | 1.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.3 | 1.9 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.3 | 1.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.3 | 0.3 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
| 0.3 | 0.3 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.3 | 0.9 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) phytoalexin metabolic process(GO:0052314) |
| 0.3 | 3.7 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.3 | 1.2 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.3 | 1.5 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 0.3 | 0.3 | GO:0035418 | protein localization to synapse(GO:0035418) |
| 0.3 | 0.3 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
| 0.3 | 1.5 | GO:2000503 | regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.3 | 3.9 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.3 | 1.2 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.3 | 0.6 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.3 | 0.9 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.3 | 3.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.3 | 0.9 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.3 | 0.9 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
| 0.3 | 1.5 | GO:0036017 | response to erythropoietin(GO:0036017) cellular response to erythropoietin(GO:0036018) |
| 0.3 | 1.2 | GO:2001301 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 0.3 | 1.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.3 | 3.7 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.3 | 1.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.3 | 0.3 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.3 | 2.3 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.3 | 0.3 | GO:0033197 | response to vitamin E(GO:0033197) |
| 0.3 | 1.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.3 | 1.1 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.3 | 1.4 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.3 | 0.8 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.3 | 3.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.3 | 1.1 | GO:0060032 | notochord regression(GO:0060032) |
| 0.3 | 2.8 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.3 | 0.3 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
| 0.3 | 1.6 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 0.3 | 0.8 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.3 | 2.5 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.3 | 0.8 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 0.3 | 2.7 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.3 | 0.3 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.3 | 0.8 | GO:0060061 | Spemann organizer formation(GO:0060061) |
| 0.3 | 0.3 | GO:0043366 | beta selection(GO:0043366) |
| 0.3 | 1.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.3 | 0.8 | GO:0015819 | lysine transport(GO:0015819) L-lysine transport(GO:1902022) |
| 0.3 | 1.9 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.3 | 1.1 | GO:1904044 | response to aldosterone(GO:1904044) |
| 0.3 | 1.1 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
| 0.3 | 2.1 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
| 0.3 | 0.3 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.3 | 3.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.3 | 2.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.3 | 3.9 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.3 | 1.0 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.3 | 0.3 | GO:0060965 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) negative regulation of gene silencing(GO:0060969) |
| 0.3 | 0.5 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
| 0.3 | 0.8 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
| 0.3 | 7.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.3 | 0.3 | GO:0071623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.3 | 0.8 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 0.3 | 1.8 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.3 | 0.3 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.3 | 0.8 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.3 | 0.8 | GO:0072573 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
| 0.3 | 7.2 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.3 | 1.8 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.3 | 10.2 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.3 | 1.8 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.3 | 1.0 | GO:0005997 | xylulose metabolic process(GO:0005997) |
| 0.3 | 0.8 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.3 | 0.8 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.3 | 0.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.2 | 0.7 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.2 | 0.7 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
| 0.2 | 1.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.2 | 3.0 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.2 | 0.7 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.2 | 0.2 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
| 0.2 | 0.7 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 0.2 | 1.0 | GO:0019400 | alditol metabolic process(GO:0019400) |
| 0.2 | 0.5 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
| 0.2 | 2.7 | GO:0034127 | regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.2 | 2.9 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.2 | 1.7 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.2 | 1.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.2 | 0.7 | GO:1900920 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
| 0.2 | 3.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.2 | 1.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.2 | 3.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.2 | 1.4 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 0.2 | 0.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.2 | 1.2 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
| 0.2 | 1.9 | GO:0035456 | response to interferon-beta(GO:0035456) |
| 0.2 | 0.5 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
| 0.2 | 0.7 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 0.2 | 0.5 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) negative regulation of bone development(GO:1903011) |
| 0.2 | 0.2 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
| 0.2 | 1.9 | GO:0032308 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
| 0.2 | 4.0 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.2 | 0.5 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
| 0.2 | 2.3 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.2 | 7.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.2 | 0.7 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 0.2 | 4.6 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.2 | 1.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.2 | 2.8 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.2 | 1.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.2 | 0.7 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 0.2 | 0.7 | GO:0032924 | activin receptor signaling pathway(GO:0032924) |
| 0.2 | 1.4 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.2 | 1.8 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.2 | 0.7 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.2 | 2.0 | GO:0003352 | regulation of cilium movement(GO:0003352) |
| 0.2 | 0.2 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
| 0.2 | 0.9 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.2 | 0.9 | GO:0031296 | B cell costimulation(GO:0031296) |
| 0.2 | 0.9 | GO:1903412 | response to bile acid(GO:1903412) |
| 0.2 | 0.2 | GO:0098907 | regulation of SA node cell action potential(GO:0098907) |
| 0.2 | 4.5 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.2 | 4.9 | GO:0006855 | drug transmembrane transport(GO:0006855) |
| 0.2 | 0.2 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
| 0.2 | 8.0 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
| 0.2 | 1.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.2 | 0.2 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.2 | 2.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.2 | 2.0 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.2 | 3.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.2 | 0.4 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
| 0.2 | 0.4 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.2 | 5.9 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.2 | 0.4 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.2 | 0.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.2 | 2.4 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
| 0.2 | 1.5 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.2 | 0.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.2 | 0.2 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
| 0.2 | 0.9 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 0.2 | 0.6 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
| 0.2 | 1.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.2 | 0.2 | GO:0006311 | meiotic gene conversion(GO:0006311) |
| 0.2 | 0.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.2 | 0.4 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
| 0.2 | 0.8 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.2 | 1.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 | 0.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 0.2 | 1.3 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.2 | 7.5 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
| 0.2 | 0.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.2 | 1.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.2 | 1.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.2 | 1.0 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.2 | 1.4 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.2 | 0.8 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.2 | 1.0 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 0.2 | 0.4 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.2 | 0.2 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
| 0.2 | 0.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.2 | 0.8 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) |
| 0.2 | 0.8 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.2 | 0.6 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.2 | 0.6 | GO:0046041 | ITP metabolic process(GO:0046041) |
| 0.2 | 1.2 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
| 0.2 | 2.8 | GO:1901678 | heme transport(GO:0015886) iron coordination entity transport(GO:1901678) |
| 0.2 | 0.6 | GO:0033058 | directional locomotion(GO:0033058) |
| 0.2 | 1.8 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.2 | 0.8 | GO:0070845 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.2 | 0.8 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.2 | 0.8 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.2 | 2.4 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
| 0.2 | 2.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.2 | 0.6 | GO:0042407 | cristae formation(GO:0042407) |
| 0.2 | 4.7 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.2 | 1.4 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.2 | 3.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.2 | 0.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.2 | 3.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.2 | 0.8 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.2 | 0.4 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.2 | 21.5 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.2 | 0.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
| 0.2 | 0.8 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
| 0.2 | 1.9 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.2 | 1.2 | GO:0030421 | defecation(GO:0030421) |
| 0.2 | 0.2 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.2 | 0.6 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 0.2 | 0.8 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.2 | 0.8 | GO:0035803 | egg coat formation(GO:0035803) |
| 0.2 | 2.7 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.2 | 0.4 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.2 | 1.3 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.2 | 2.3 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
| 0.2 | 6.0 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.2 | 21.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.2 | 0.8 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.2 | 0.9 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.2 | 2.6 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.2 | 0.2 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.2 | 0.4 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.2 | 0.7 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.2 | 0.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.2 | 1.7 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.2 | 3.1 | GO:0048557 | embryonic digestive tract morphogenesis(GO:0048557) |
| 0.2 | 0.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.2 | 0.6 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.2 | 1.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.2 | 1.8 | GO:0006582 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 0.2 | 0.5 | GO:1902993 | positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
| 0.2 | 6.9 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.2 | 1.3 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.2 | 1.1 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.2 | 1.8 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 0.2 | 1.8 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.2 | 0.2 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.2 | 1.8 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
| 0.2 | 0.4 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.2 | 0.4 | GO:0061743 | motor learning(GO:0061743) |
| 0.2 | 0.5 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 0.2 | 0.5 | GO:0072616 | interleukin-18 secretion(GO:0072616) |
| 0.2 | 1.1 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.2 | 1.1 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.2 | 0.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.2 | 1.4 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.2 | 0.9 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 0.2 | 0.4 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.2 | 0.5 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.2 | 0.4 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.2 | 1.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.2 | 0.5 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.2 | 1.1 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.2 | 1.6 | GO:0035912 | dorsal aorta morphogenesis(GO:0035912) |
| 0.2 | 0.7 | GO:1990535 | neuron projection maintenance(GO:1990535) |
| 0.2 | 2.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.2 | 0.2 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
| 0.2 | 0.5 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.2 | 0.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.2 | 2.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.2 | 2.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.2 | 0.7 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.2 | 1.0 | GO:0010872 | regulation of cholesterol esterification(GO:0010872) |
| 0.2 | 0.9 | GO:2001183 | negative regulation of interleukin-10 secretion(GO:2001180) negative regulation of interleukin-12 secretion(GO:2001183) |
| 0.2 | 0.2 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
| 0.2 | 0.5 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
| 0.2 | 0.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
| 0.2 | 1.9 | GO:0036503 | ERAD pathway(GO:0036503) |
| 0.2 | 0.5 | GO:0007343 | egg activation(GO:0007343) female pronucleus assembly(GO:0035038) |
| 0.2 | 0.8 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.2 | 0.5 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.2 | 1.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.2 | 1.3 | GO:0044211 | CTP salvage(GO:0044211) |
| 0.2 | 0.7 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.2 | 1.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.2 | 0.8 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.2 | 0.7 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.2 | 0.7 | GO:1903949 | positive regulation of actin filament-based movement(GO:1903116) positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
| 0.2 | 0.5 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
| 0.2 | 0.3 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
| 0.2 | 1.5 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.2 | 5.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.2 | 3.2 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.2 | 2.9 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 0.2 | 0.5 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.2 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.2 | 0.2 | GO:0044027 | UDP-glucose catabolic process(GO:0006258) hypermethylation of CpG island(GO:0044027) |
| 0.2 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.2 | 1.3 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 0.2 | 0.2 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 0.2 | 1.0 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.2 | 0.3 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.2 | 0.2 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
| 0.2 | 2.7 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.2 | 0.6 | GO:0061525 | hindgut development(GO:0061525) |
| 0.2 | 1.4 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.2 | 0.5 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.2 | 0.3 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
| 0.2 | 0.9 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.2 | 3.6 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.2 | 0.9 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.2 | 2.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.2 | 1.4 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.2 | 3.3 | GO:1902884 | positive regulation of response to oxidative stress(GO:1902884) |
| 0.2 | 1.6 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.2 | 0.3 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.2 | 0.5 | GO:0010259 | multicellular organism aging(GO:0010259) |
| 0.2 | 1.1 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.2 | 0.5 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.2 | 2.9 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.2 | 0.6 | GO:0045208 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.2 | 1.5 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.2 | 0.6 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.2 | 18.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.2 | 0.8 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) |
| 0.2 | 0.2 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
| 0.2 | 0.2 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.2 | 0.9 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.2 | 0.8 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.2 | 1.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.2 | 0.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.2 | 2.6 | GO:0015865 | purine nucleotide transport(GO:0015865) |
| 0.2 | 0.5 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.1 | 0.7 | GO:0045337 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 0.1 | 0.9 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.1 | 0.6 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
| 0.1 | 0.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.1 | 1.0 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
| 0.1 | 0.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.1 | 0.1 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.1 | 1.0 | GO:0019835 | cytolysis(GO:0019835) |
| 0.1 | 3.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.1 | 0.7 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.1 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 | 0.7 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.1 | 0.7 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.1 | 3.5 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 | 1.2 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.1 | 1.0 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 | 1.0 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.1 | 0.3 | GO:0046541 | saliva secretion(GO:0046541) |
| 0.1 | 19.9 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 | 0.3 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
| 0.1 | 1.0 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.1 | 7.4 | GO:0006735 | NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.1 | 0.6 | GO:1902869 | regulation of amacrine cell differentiation(GO:1902869) |
| 0.1 | 0.6 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
| 0.1 | 0.8 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
| 0.1 | 7.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 | 0.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 0.1 | 0.8 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.1 | 0.3 | GO:0051891 | endodermal cell fate determination(GO:0007493) positive regulation of cardioblast differentiation(GO:0051891) |
| 0.1 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.1 | 0.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.1 | 0.6 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.1 | 0.7 | GO:0060606 | neural tube closure(GO:0001843) tube closure(GO:0060606) |
| 0.1 | 0.4 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.1 | 0.1 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
| 0.1 | 0.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 0.1 | 0.4 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.1 | 0.3 | GO:0052501 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.1 | 0.4 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.1 | 0.4 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.1 | 0.4 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.1 | 0.8 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.1 | 0.4 | GO:1903781 | positive regulation of cardiac conduction(GO:1903781) |
| 0.1 | 0.8 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 0.5 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.1 | 1.8 | GO:0051938 | L-glutamate import(GO:0051938) |
| 0.1 | 0.4 | GO:0021860 | pyramidal neuron development(GO:0021860) |
| 0.1 | 0.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 | 0.8 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 | 1.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.1 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
| 0.1 | 0.4 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 0.1 | 0.4 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.1 | 0.8 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.1 | 2.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 | 1.1 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.1 | 1.1 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 0.1 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.1 | 0.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 | 0.5 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.1 | 0.5 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.1 | 0.4 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.1 | 0.7 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
| 0.1 | 0.4 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.1 | 2.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 | 0.5 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
| 0.1 | 0.9 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.1 | 0.6 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.1 | 1.2 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.1 | 0.3 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
| 0.1 | 0.3 | GO:0046677 | response to antibiotic(GO:0046677) |
| 0.1 | 1.0 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 | 1.9 | GO:0035878 | nail development(GO:0035878) |
| 0.1 | 0.4 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.1 | 0.6 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.1 | 0.4 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 | 0.6 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 | 0.8 | GO:0036309 | protein localization to M-band(GO:0036309) |
| 0.1 | 0.4 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 0.1 | 0.3 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
| 0.1 | 0.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.1 | 0.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
| 0.1 | 1.4 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 | 0.4 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.1 | 1.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.1 | 0.4 | GO:0046709 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.1 | 0.5 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.1 | 0.2 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
| 0.1 | 0.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.1 | 0.5 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.1 | 1.3 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.1 | 0.1 | GO:0045582 | positive regulation of T cell differentiation(GO:0045582) |
| 0.1 | 0.5 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 | 1.0 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 0.1 | 0.5 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.1 | 0.4 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.1 | 4.8 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.1 | 0.2 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.1 | 1.7 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.1 | 2.4 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.1 | 1.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.1 | 2.5 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.1 | 1.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.1 | 0.7 | GO:0070672 | response to interleukin-15(GO:0070672) |
| 0.1 | 0.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 | 0.5 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 | 0.5 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.1 | 1.6 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.1 | 1.9 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 0.1 | 1.0 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.1 | 1.4 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 | 0.3 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
| 0.1 | 0.7 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 0.1 | 1.3 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.1 | 0.5 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.1 | 0.7 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.1 | 0.1 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
| 0.1 | 7.1 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
| 0.1 | 1.9 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.1 | 1.0 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
| 0.1 | 0.7 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.1 | 1.3 | GO:0030238 | male sex determination(GO:0030238) |
| 0.1 | 1.8 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.1 | 2.0 | GO:0060972 | left/right pattern formation(GO:0060972) |
| 0.1 | 0.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
| 0.1 | 0.6 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 | 1.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.1 | 0.6 | GO:1903307 | positive regulation of regulated secretory pathway(GO:1903307) |
| 0.1 | 0.8 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
| 0.1 | 0.4 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 | 1.0 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 | 0.2 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 | 1.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 | 1.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.1 | 14.6 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.1 | 1.6 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.1 | 1.3 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.1 | 0.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 | 0.4 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
| 0.1 | 2.5 | GO:0006734 | NADH metabolic process(GO:0006734) |
| 0.1 | 0.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 | 1.0 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.1 | 1.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 | 3.9 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
| 0.1 | 0.3 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.1 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.1 | 0.3 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 | 0.6 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 | 0.2 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.1 | 0.5 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
| 0.1 | 1.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.1 | 0.3 | GO:0070409 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
| 0.1 | 0.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.1 | 2.4 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 | 0.1 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 0.1 | 0.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 | 0.3 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.1 | 0.3 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
| 0.1 | 0.1 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.1 | 0.1 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.1 | 0.8 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.1 | 0.3 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
| 0.1 | 1.1 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
| 0.1 | 1.2 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.1 | 0.3 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.1 | 0.2 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 | 0.3 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
| 0.1 | 0.1 | GO:0002664 | regulation of T cell tolerance induction(GO:0002664) |
| 0.1 | 0.5 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.1 | 1.6 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 | 0.3 | GO:1904586 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
| 0.1 | 0.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.1 | 0.7 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 | 0.2 | GO:0045423 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
| 0.1 | 0.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.1 | 0.5 | GO:0052150 | modulation by symbiont of host apoptotic process(GO:0052150) |
| 0.1 | 1.1 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 | 4.6 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 | 2.0 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.1 | 0.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.1 | 0.1 | GO:0019081 | viral translation(GO:0019081) |
| 0.1 | 0.4 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
| 0.1 | 0.4 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.1 | 0.2 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
| 0.1 | 1.1 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.1 | 0.2 | GO:0002027 | regulation of heart rate(GO:0002027) |
| 0.1 | 0.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.1 | 1.5 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.1 | 0.3 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.1 | 0.4 | GO:0048663 | neuron fate commitment(GO:0048663) |
| 0.1 | 2.0 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 | 0.8 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
| 0.1 | 1.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 | 0.6 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 0.1 | 0.8 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.1 | 0.5 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.1 | 0.1 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
| 0.1 | 1.3 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.1 | 1.9 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 | 1.5 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.1 | 1.7 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.1 | 1.2 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
| 0.1 | 0.3 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.1 | 0.2 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
| 0.1 | 0.4 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 | 0.1 | GO:0001696 | gastric acid secretion(GO:0001696) |
| 0.1 | 0.4 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 0.1 | GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.1 | 0.7 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.1 | 0.8 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 0.1 | 0.1 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) positive regulation of T-helper 1 type immune response(GO:0002827) |
| 0.1 | 0.5 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.1 | 0.4 | GO:0001554 | luteolysis(GO:0001554) |
| 0.1 | 0.3 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.1 | 0.9 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 0.1 | 0.3 | GO:0034344 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.1 | 0.6 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.1 | 0.7 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.1 | 1.0 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.1 | 0.8 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
| 0.1 | 3.1 | GO:0097503 | sialylation(GO:0097503) |
| 0.1 | 0.4 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 0.1 | 0.7 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.1 | 0.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.1 | 0.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.1 | 0.3 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.1 | 0.3 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
| 0.1 | 0.3 | GO:1904617 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
| 0.1 | 0.2 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.1 | 0.2 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.1 | 1.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 | 0.6 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 | 0.1 | GO:1904798 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
| 0.1 | 0.3 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.1 | 0.2 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.1 | 0.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 | 0.4 | GO:0010732 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.1 | 0.6 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.1 | 0.2 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
| 0.1 | 1.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.1 | 0.3 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
| 0.1 | 0.6 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 | 0.2 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 | 2.9 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.1 | 0.2 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 0.1 | 0.9 | GO:0010996 | response to auditory stimulus(GO:0010996) |
| 0.1 | 0.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 | 0.2 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.1 | 0.5 | GO:0098758 | interleukin-8-mediated signaling pathway(GO:0038112) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.1 | 0.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 | 0.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.1 | 0.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.1 | 1.6 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.1 | 0.3 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.1 | 0.5 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
| 0.1 | 5.9 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.1 | 0.2 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.1 | 0.6 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.1 | 1.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.1 | 0.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 | 0.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.1 | 0.1 | GO:1902616 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.1 | 0.1 | GO:0032414 | positive regulation of ion transmembrane transporter activity(GO:0032414) |
| 0.1 | 2.6 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
| 0.1 | 0.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.1 | 0.3 | GO:0021885 | forebrain cell migration(GO:0021885) |
| 0.1 | 0.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.1 | 2.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.1 | 0.7 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 | 0.4 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 | 0.9 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.1 | 0.2 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
| 0.1 | 0.9 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.1 | 0.1 | GO:0009261 | purine ribonucleotide catabolic process(GO:0009154) ribonucleotide catabolic process(GO:0009261) |
| 0.1 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.1 | 0.8 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 | 0.8 | GO:0003416 | endochondral bone growth(GO:0003416) |
| 0.1 | 0.2 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.1 | 0.2 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.1 | 1.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.1 | 0.5 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 | 0.3 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.1 | 0.2 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.1 | 0.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.1 | 0.2 | GO:1902598 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.1 | 0.4 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
| 0.1 | 0.3 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.1 | 0.1 | GO:0032736 | positive regulation of interleukin-13 production(GO:0032736) |
| 0.1 | 0.3 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.1 | 0.9 | GO:0060074 | synapse maturation(GO:0060074) |
| 0.1 | 0.8 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.1 | 0.3 | GO:0019732 | antifungal humoral response(GO:0019732) |
| 0.1 | 0.3 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.1 | 0.3 | GO:0019098 | reproductive behavior(GO:0019098) maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.1 | 0.1 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
| 0.1 | 0.2 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
| 0.1 | 0.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.1 | 0.8 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 | 0.5 | GO:0001881 | receptor recycling(GO:0001881) |
| 0.1 | 0.6 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.1 | 0.4 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.1 | 0.1 | GO:0002467 | germinal center formation(GO:0002467) |
| 0.1 | 0.2 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 0.1 | 0.7 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.1 | 0.1 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 0.1 | 0.2 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.1 | 0.1 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
| 0.1 | 0.9 | GO:0048665 | neuron fate specification(GO:0048665) |
| 0.1 | 1.1 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.1 | 2.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.1 | 0.1 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.1 | 2.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.1 | 0.4 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.1 | 0.3 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.1 | 0.3 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.1 | 0.4 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.1 | 0.3 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.1 | 0.2 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
| 0.1 | 0.7 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.1 | 1.7 | GO:0097502 | mannosylation(GO:0097502) |
| 0.1 | 0.3 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
| 0.1 | 0.4 | GO:1902679 | negative regulation of RNA biosynthetic process(GO:1902679) |
| 0.1 | 0.2 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.1 | 0.6 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 0.2 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
| 0.1 | 0.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.1 | 0.8 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.1 | 0.7 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.1 | 4.9 | GO:0072376 | protein activation cascade(GO:0072376) |
| 0.1 | 0.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 | 0.1 | GO:0002911 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.1 | 0.2 | GO:0019605 | butyrate metabolic process(GO:0019605) |
| 0.1 | 0.1 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
| 0.1 | 0.1 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
| 0.1 | 0.2 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.1 | 0.4 | GO:0032329 | L-serine transport(GO:0015825) serine transport(GO:0032329) |
| 0.1 | 0.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.1 | 0.7 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
| 0.1 | 2.5 | GO:0035036 | sperm-egg recognition(GO:0035036) |
| 0.1 | 1.7 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 | 0.6 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.1 | 0.8 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.1 | 0.2 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
| 0.1 | 0.8 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.1 | 0.3 | GO:0031337 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.1 | 0.6 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.1 | 0.3 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 0.1 | 0.5 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.1 | 0.8 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.1 | 0.6 | GO:0048265 | response to pain(GO:0048265) |
| 0.1 | 0.2 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
| 0.1 | 0.1 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.1 | 0.3 | GO:0046958 | nonassociative learning(GO:0046958) |
| 0.1 | 0.1 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.1 | 0.2 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.1 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 | 0.6 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 | 0.6 | GO:0016556 | mRNA modification(GO:0016556) |
| 0.1 | 0.2 | GO:0002544 | chronic inflammatory response(GO:0002544) |
| 0.1 | 0.5 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.1 | 0.3 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.1 | 0.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.1 | 0.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.1 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 | 0.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.1 | 1.3 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.1 | 0.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.1 | 0.2 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 0.1 | 0.5 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.1 | 0.4 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
| 0.1 | 0.4 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.1 | 0.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 | 0.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 | 1.7 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.1 | 0.2 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.1 | 0.1 | GO:0030647 | glycoside metabolic process(GO:0016137) aminoglycoside antibiotic metabolic process(GO:0030647) |
| 0.1 | 0.8 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.1 | 2.2 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
| 0.1 | 0.1 | GO:0042116 | macrophage activation(GO:0042116) |
| 0.1 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
| 0.1 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 | 0.7 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
| 0.1 | 0.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.1 | 0.5 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
| 0.1 | 0.7 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.1 | 0.2 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
| 0.1 | 0.3 | GO:0000154 | rRNA modification(GO:0000154) |
| 0.1 | 2.0 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 | 1.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 0.4 | GO:0035082 | axoneme assembly(GO:0035082) |
| 0.1 | 0.5 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
| 0.1 | 0.3 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
| 0.1 | 0.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.1 | 0.8 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 | 0.2 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
| 0.0 | 0.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.0 | 0.9 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.0 | 0.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.0 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
| 0.0 | 0.8 | GO:0097066 | response to thyroid hormone(GO:0097066) |
| 0.0 | 1.0 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.0 | 0.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 0.0 | 0.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.0 | 0.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.0 | 0.1 | GO:1901656 | glycoside transport(GO:1901656) |
| 0.0 | 0.2 | GO:0010324 | membrane invagination(GO:0010324) |
| 0.0 | 0.1 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.0 | 1.2 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.0 | 0.1 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 0.0 | 0.8 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
| 0.0 | 0.1 | GO:0021545 | cranial nerve development(GO:0021545) |
| 0.0 | 0.0 | GO:0007320 | insemination(GO:0007320) |
| 0.0 | 0.6 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
| 0.0 | 0.1 | GO:0060380 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.0 | 0.1 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.0 | 0.1 | GO:0003139 | secondary heart field specification(GO:0003139) |
| 0.0 | 0.2 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.0 | 0.1 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.0 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.0 | 0.0 | GO:0008210 | estrogen metabolic process(GO:0008210) |
| 0.0 | 0.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.0 | 0.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.0 | 0.2 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
| 0.0 | 0.4 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.0 | 0.1 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
| 0.0 | 0.2 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.0 | 0.3 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.0 | 0.1 | GO:0044026 | DNA hypermethylation(GO:0044026) |
| 0.0 | 0.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.0 | 0.2 | GO:0001510 | RNA methylation(GO:0001510) |
| 0.0 | 0.0 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
| 0.0 | 0.3 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.0 | 0.3 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) positive regulation of natural killer cell cytokine production(GO:0002729) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
| 0.0 | 0.7 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 | 0.1 | GO:0002001 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
| 0.0 | 0.1 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
| 0.0 | 0.4 | GO:0018065 | protein lipoylation(GO:0009249) protein-cofactor linkage(GO:0018065) |
| 0.0 | 0.1 | GO:0042335 | cuticle development(GO:0042335) |
| 0.0 | 0.2 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.0 | 0.1 | GO:0042214 | terpene metabolic process(GO:0042214) |
| 0.0 | 0.3 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.0 | 0.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.0 | 0.4 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 | 0.5 | GO:0015695 | organic cation transport(GO:0015695) |
| 0.0 | 1.4 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
| 0.0 | 0.1 | GO:0051758 | homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
| 0.0 | 0.7 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.0 | 0.1 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
| 0.0 | 0.1 | GO:0006195 | purine nucleotide catabolic process(GO:0006195) |
| 0.0 | 0.4 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 | 0.3 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.0 | 0.2 | GO:0032099 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.0 | 0.3 | GO:0032098 | regulation of appetite(GO:0032098) |
| 0.0 | 1.0 | GO:0070206 | protein trimerization(GO:0070206) |
| 0.0 | 0.3 | GO:0060736 | prostate gland growth(GO:0060736) |
| 0.0 | 0.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.0 | 1.1 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.0 | 0.0 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.0 | 0.1 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.0 | 0.1 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 0.0 | 0.6 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 | 0.4 | GO:0046548 | retinal rod cell development(GO:0046548) |
| 0.0 | 0.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.0 | 1.3 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 | 0.0 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.0 | 0.0 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
| 0.0 | 0.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.0 | 0.2 | GO:0044062 | regulation of excretion(GO:0044062) |
| 0.0 | 0.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 0.0 | 0.4 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.0 | 0.2 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.0 | 0.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.0 | 0.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 | 0.4 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 | 0.1 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.0 | 0.0 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
| 0.0 | 0.4 | GO:0045576 | mast cell activation(GO:0045576) |
| 0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
| 0.0 | 0.3 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.0 | 3.0 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.0 | 0.7 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.0 | 0.4 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
| 0.0 | 0.7 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
| 0.0 | 0.1 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.0 | 0.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 0.0 | 0.1 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 0.0 | 0.3 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
| 0.0 | 0.1 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 0.0 | 0.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.0 | 0.5 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
| 0.0 | 0.1 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
| 0.0 | 0.1 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
| 0.0 | 0.0 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.0 | 0.2 | GO:0072093 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 0.0 | 0.6 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 | 0.0 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
| 0.0 | 0.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 | 0.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 | 0.2 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.0 | 0.1 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.0 | 0.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 0.0 | 0.1 | GO:0006544 | glycine metabolic process(GO:0006544) |
| 0.0 | 0.5 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
| 0.0 | 0.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.0 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 | 0.3 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.0 | 0.1 | GO:0007528 | neuromuscular junction development(GO:0007528) |
| 0.0 | 0.7 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.0 | 0.1 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
| 0.0 | 0.1 | GO:0014904 | myotube cell development(GO:0014904) |
| 0.0 | 0.1 | GO:1990668 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
| 0.0 | 0.1 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
| 0.0 | 0.2 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.0 | 0.1 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
| 0.0 | 0.2 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
| 0.0 | 0.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.0 | 0.1 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
| 0.0 | 0.2 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
| 0.0 | 0.3 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
| 0.0 | 0.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
| 0.0 | 0.3 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.0 | 0.1 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
| 0.0 | 0.2 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.0 | 0.1 | GO:0042701 | progesterone secretion(GO:0042701) |
| 0.0 | 0.9 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 0.0 | 0.1 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.0 | 0.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.0 | 0.4 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.0 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.0 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.0 | 0.5 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.0 | 0.1 | GO:0071025 | RNA surveillance(GO:0071025) |
| 0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 | 0.2 | GO:0055070 | copper ion homeostasis(GO:0055070) |
| 0.0 | 0.2 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
| 0.0 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.0 | 0.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.0 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.0 | 0.1 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.0 | 0.1 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) |
| 0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 0.0 | 0.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.0 | 0.1 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.0 | 0.5 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.0 | 0.2 | GO:0045137 | development of primary sexual characteristics(GO:0045137) |
| 0.0 | 0.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.0 | 0.1 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.0 | 0.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.0 | 0.2 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.0 | 0.2 | GO:0001505 | regulation of neurotransmitter levels(GO:0001505) |
| 0.0 | 0.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.0 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
| 0.0 | 0.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.0 | 0.1 | GO:0061046 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 0.0 | 0.2 | GO:1900115 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.0 | 0.1 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
| 0.0 | 0.0 | GO:0072014 | proximal tubule development(GO:0072014) |
| 0.0 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.0 | 0.1 | GO:1902159 | transepithelial water transport(GO:0035377) regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 0.0 | 0.0 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
| 0.0 | 0.2 | GO:0030728 | ovulation(GO:0030728) |
| 0.0 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
| 0.0 | 0.3 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
| 0.0 | 0.4 | GO:0006536 | glutamate metabolic process(GO:0006536) |
| 0.0 | 0.4 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.0 | 0.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.0 | 0.1 | GO:1902661 | positive regulation of glucose mediated signaling pathway(GO:1902661) |
| 0.0 | 0.0 | GO:0086091 | regulation of heart rate by cardiac conduction(GO:0086091) |
| 0.0 | 0.1 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.0 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.0 | 0.1 | GO:0046351 | sucrose biosynthetic process(GO:0005986) disaccharide biosynthetic process(GO:0046351) |
| 0.0 | 0.1 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.0 | 0.0 | GO:0021854 | hypothalamus development(GO:0021854) |
| 0.0 | 1.0 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.0 | 0.3 | GO:0031054 | pre-miRNA processing(GO:0031054) |
| 0.0 | 0.2 | GO:0018904 | ether metabolic process(GO:0018904) |
| 0.0 | 0.1 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
| 0.0 | 0.2 | GO:0006591 | ornithine metabolic process(GO:0006591) |
| 0.0 | 1.3 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 0.0 | 0.1 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
| 0.0 | 0.0 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
| 0.0 | 0.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
| 0.0 | 0.1 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
| 0.0 | 0.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.0 | 0.1 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
| 0.0 | 0.2 | GO:0006554 | lysine catabolic process(GO:0006554) |
| 0.0 | 0.1 | GO:0046643 | regulation of gamma-delta T cell activation(GO:0046643) |
| 0.0 | 0.3 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.0 | 0.3 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.0 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.0 | 1.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 | 0.1 | GO:0055072 | iron ion homeostasis(GO:0055072) |
| 0.0 | 0.0 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.0 | 0.1 | GO:0007625 | grooming behavior(GO:0007625) |
| 0.0 | 0.0 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
| 0.0 | 0.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.0 | 0.1 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.0 | 0.1 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.0 | 0.1 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.0 | 0.2 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.0 | 0.1 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
| 0.0 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.0 | 0.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.0 | 0.1 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.0 | 0.0 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.0 | 0.1 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 0.0 | 0.1 | GO:0036315 | cellular response to sterol(GO:0036315) |
| 0.0 | 0.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.0 | 0.2 | GO:0098743 | cell aggregation(GO:0098743) |
| 0.0 | 0.0 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.0 | 0.1 | GO:0019627 | urea metabolic process(GO:0019627) nitrogen cycle metabolic process(GO:0071941) |
| 0.0 | 0.3 | GO:0019935 | cyclic-nucleotide-mediated signaling(GO:0019935) |
| 0.0 | 0.2 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.0 | 0.1 | GO:0042428 | serotonin metabolic process(GO:0042428) |
| 0.0 | 0.1 | GO:0021902 | forebrain neuron fate commitment(GO:0021877) commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.0 | 0.1 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.0 | 0.1 | GO:0001659 | temperature homeostasis(GO:0001659) |
| 0.0 | 0.1 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
| 0.0 | 0.2 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.0 | 0.0 | GO:0050764 | regulation of phagocytosis(GO:0050764) |
| 0.0 | 0.0 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
| 0.0 | 0.2 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.0 | 0.2 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.0 | 0.0 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.0 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.0 | 0.1 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
| 0.0 | 0.0 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.0 | 0.6 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 | 0.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 0.0 | 0.0 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
| 0.0 | 0.1 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
| 0.0 | 0.0 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.0 | 0.0 | GO:0003170 | heart valve development(GO:0003170) |
| 0.0 | 0.1 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
| 0.0 | 0.0 | GO:0045006 | DNA deamination(GO:0045006) DNA cytosine deamination(GO:0070383) |
| 0.0 | 0.1 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.0 | 0.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.0 | 0.3 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.0 | 0.0 | GO:0014888 | striated muscle adaptation(GO:0014888) |
| 0.0 | 0.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 | 0.1 | GO:0003351 | epithelial cilium movement(GO:0003351) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.3 | 6.8 | GO:0098855 | HCN channel complex(GO:0098855) |
| 1.8 | 7.3 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 1.6 | 12.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 1.2 | 7.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 1.1 | 4.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 1.0 | 5.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 1.0 | 5.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 1.0 | 3.0 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.9 | 9.1 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.9 | 9.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.8 | 7.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.8 | 3.8 | GO:0070701 | mucus layer(GO:0070701) |
| 0.7 | 5.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.7 | 3.5 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.7 | 11.9 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.6 | 5.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.6 | 5.0 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.6 | 9.4 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.6 | 2.4 | GO:0097196 | Shu complex(GO:0097196) |
| 0.6 | 8.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.6 | 1.8 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
| 0.6 | 1.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.6 | 3.4 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.5 | 3.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 0.5 | 6.9 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.5 | 13.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.5 | 4.2 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.5 | 1.5 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 0.5 | 1.4 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.5 | 8.3 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.5 | 2.7 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.5 | 0.5 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
| 0.5 | 0.9 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.4 | 8.5 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.4 | 3.5 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.4 | 4.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
| 0.4 | 0.8 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.4 | 1.3 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.4 | 5.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.4 | 3.5 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.4 | 1.6 | GO:0032009 | early phagosome(GO:0032009) |
| 0.4 | 2.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.4 | 2.7 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
| 0.4 | 1.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.4 | 1.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.4 | 1.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.4 | 1.5 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.4 | 2.6 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.4 | 1.5 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 0.4 | 6.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.4 | 2.5 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.4 | 2.9 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.4 | 0.7 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.4 | 1.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.3 | 2.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.3 | 0.7 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.3 | 4.8 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.3 | 25.8 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.3 | 2.7 | GO:0043196 | varicosity(GO:0043196) |
| 0.3 | 0.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.3 | 12.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.3 | 5.5 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 0.3 | 1.9 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.3 | 2.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.3 | 2.1 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.3 | 9.9 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.3 | 0.9 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.3 | 1.4 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.3 | 2.8 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.3 | 0.3 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.3 | 7.1 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.3 | 3.0 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.3 | 1.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.3 | 1.3 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.3 | 2.1 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.3 | 1.1 | GO:1990742 | microvesicle(GO:1990742) |
| 0.3 | 1.8 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.3 | 0.8 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.3 | 45.7 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.3 | 3.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.3 | 1.8 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.3 | 1.5 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.2 | 2.0 | GO:0070695 | FHF complex(GO:0070695) |
| 0.2 | 2.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.2 | 0.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.2 | 1.2 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.2 | 2.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.2 | 4.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.2 | 6.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.2 | 1.9 | GO:0097361 | CIA complex(GO:0097361) |
| 0.2 | 0.7 | GO:0005608 | laminin-3 complex(GO:0005608) |
| 0.2 | 0.7 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 0.2 | 5.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.2 | 1.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.2 | 16.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.2 | 4.6 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.2 | 0.6 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.2 | 1.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.2 | 0.6 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.2 | 3.8 | GO:0005861 | troponin complex(GO:0005861) |
| 0.2 | 2.1 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 0.2 | 2.7 | GO:0000243 | commitment complex(GO:0000243) |
| 0.2 | 1.0 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.2 | 2.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.2 | 9.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.2 | 0.8 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.2 | 0.8 | GO:0031251 | PAN complex(GO:0031251) |
| 0.2 | 3.4 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.2 | 0.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.2 | 1.5 | GO:0071203 | WASH complex(GO:0071203) |
| 0.2 | 3.8 | GO:0036038 | MKS complex(GO:0036038) |
| 0.2 | 21.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.2 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.2 | 2.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.2 | 1.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.2 | 1.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.2 | 1.2 | GO:0098536 | deuterosome(GO:0098536) |
| 0.2 | 11.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.2 | 4.2 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.2 | 1.6 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 0.2 | 0.3 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 0.2 | 18.9 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.2 | 1.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.2 | 1.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.2 | 0.8 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.2 | 3.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.2 | 0.8 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.2 | 0.8 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.2 | 1.8 | GO:0097227 | sperm annulus(GO:0097227) |
| 0.2 | 3.0 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.2 | 4.3 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.2 | 0.8 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.2 | 0.8 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.2 | 0.2 | GO:0044393 | microspike(GO:0044393) |
| 0.2 | 1.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.1 | 1.3 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.1 | 11.4 | GO:0044391 | small ribosomal subunit(GO:0015935) ribosomal subunit(GO:0044391) |
| 0.1 | 0.9 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.1 | 1.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.1 | 0.3 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 0.1 | 1.3 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.1 | 0.6 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.1 | 1.0 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.1 | 3.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.1 | 0.4 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
| 0.1 | 13.6 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.1 | 0.4 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.1 | 0.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.1 | 0.4 | GO:0001534 | radial spoke(GO:0001534) |
| 0.1 | 0.7 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 0.1 | 0.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.1 | 0.4 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
| 0.1 | 0.6 | GO:0071547 | piP-body(GO:0071547) |
| 0.1 | 0.5 | GO:0055087 | Ski complex(GO:0055087) |
| 0.1 | 0.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.1 | 2.4 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.1 | 0.1 | GO:0097441 | basilar dendrite(GO:0097441) |
| 0.1 | 2.5 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.1 | 0.4 | GO:0030689 | Noc complex(GO:0030689) |
| 0.1 | 0.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.1 | 5.9 | GO:0031430 | M band(GO:0031430) |
| 0.1 | 1.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 0.1 | 1.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.1 | 0.8 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.1 | 4.2 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.1 | 0.9 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.1 | 0.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.1 | 1.0 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.1 | 1.1 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.1 | 0.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.1 | 0.8 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.1 | 0.8 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.1 | 1.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.1 | 14.9 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 0.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.1 | 6.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.1 | 0.6 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.1 | 9.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 0.2 | GO:0034657 | GID complex(GO:0034657) |
| 0.1 | 7.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.1 | 0.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.1 | 0.4 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.1 | 0.6 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 0.3 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.1 | 0.3 | GO:0097413 | Lewy body(GO:0097413) |
| 0.1 | 0.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.1 | 0.8 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 0.1 | 0.5 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.1 | 1.0 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.1 | 3.5 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 2.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.1 | 1.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.1 | 1.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.1 | 0.3 | GO:0002133 | polycystin complex(GO:0002133) |
| 0.1 | 0.2 | GO:0097182 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 0.1 | 0.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.1 | 0.9 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.1 | 0.8 | GO:0001741 | XY body(GO:0001741) |
| 0.1 | 0.2 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.1 | 0.3 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 0.1 | 0.5 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.1 | 1.5 | GO:0030315 | T-tubule(GO:0030315) |
| 0.1 | 1.8 | GO:0030673 | axolemma(GO:0030673) |
| 0.1 | 0.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.1 | 3.3 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 0.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.1 | 0.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 0.1 | 0.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
| 0.1 | 0.4 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.1 | 2.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.1 | 0.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.1 | 0.3 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
| 0.1 | 0.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.1 | 0.4 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.1 | 0.6 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.1 | 0.2 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
| 0.1 | 1.5 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.1 | 0.3 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.1 | 0.2 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.1 | 4.6 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 0.2 | GO:0044455 | mitochondrial membrane part(GO:0044455) |
| 0.1 | 7.4 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.1 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.1 | 0.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.1 | 0.6 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.1 | 0.3 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.1 | 2.1 | GO:0008305 | integrin complex(GO:0008305) |
| 0.1 | 0.8 | GO:0030681 | multimeric ribonuclease P complex(GO:0030681) |
| 0.1 | 0.3 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.1 | 0.5 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.1 | 0.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.1 | 2.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.1 | 2.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.1 | 1.2 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.1 | 0.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.1 | 0.2 | GO:0070685 | macropinocytic cup(GO:0070685) |
| 0.1 | 0.6 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.1 | 0.3 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
| 0.1 | 4.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.1 | 0.5 | GO:0000801 | central element(GO:0000801) |
| 0.1 | 0.3 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.0 | 0.1 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.0 | 3.3 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.0 | 0.1 | GO:0035841 | new growing cell tip(GO:0035841) |
| 0.0 | 16.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 1.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.0 | 0.4 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.0 | 0.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.0 | 7.0 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.0 | 0.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.0 | 2.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.0 | 1.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 1.2 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.0 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.0 | 0.4 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.0 | 0.8 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 1.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.0 | 0.0 | GO:0097179 | protease inhibitor complex(GO:0097179) |
| 0.0 | 0.3 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.0 | 0.3 | GO:0005921 | gap junction(GO:0005921) |
| 0.0 | 1.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.0 | 0.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 0.0 | 0.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.0 | 61.9 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 1.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.0 | 2.5 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.0 | 0.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.0 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
| 0.0 | 0.2 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.0 | 1.0 | GO:0032420 | stereocilium(GO:0032420) |
| 0.0 | 0.2 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
| 0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.0 | 16.2 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.0 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.0 | 0.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.0 | 4.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.0 | 0.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.0 | 0.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.0 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.0 | 0.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.0 | 0.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.0 | 0.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
| 0.0 | 0.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.0 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.0 | 0.6 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.0 | 0.2 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.0 | 0.2 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.0 | 3.2 | GO:0043679 | axon terminus(GO:0043679) |
| 0.0 | 0.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.0 | 0.3 | GO:0097433 | dense body(GO:0097433) |
| 0.0 | 0.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.0 | 0.3 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
| 0.0 | 164.6 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.0 | 0.0 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.0 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
| 0.0 | 0.1 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.0 | 0.5 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
| 0.0 | 0.6 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.0 | 0.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.0 | 0.3 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.0 | 0.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.0 | 0.1 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.0 | 0.1 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.0 | 0.3 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.0 | 0.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.0 | 0.2 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
| 0.0 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
| 0.0 | 0.1 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
| 0.0 | 0.0 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
| 0.0 | 0.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.0 | 0.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.0 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.8 | 11.3 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 2.9 | 8.6 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 2.5 | 7.5 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 2.5 | 7.5 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 2.3 | 6.9 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 1.7 | 6.8 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 1.7 | 10.1 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 1.5 | 4.6 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 1.4 | 4.2 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 1.4 | 6.9 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 1.4 | 6.9 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 1.3 | 3.9 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
| 1.3 | 6.5 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 1.3 | 3.9 | GO:0019862 | IgA binding(GO:0019862) |
| 1.3 | 5.1 | GO:0090556 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 1.3 | 2.5 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
| 1.3 | 3.8 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 1.3 | 1.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 1.2 | 3.7 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 1.2 | 3.6 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
| 1.2 | 3.6 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
| 1.2 | 3.6 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 1.1 | 13.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 1.1 | 4.6 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 1.1 | 3.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 1.1 | 9.0 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 1.1 | 4.4 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 1.1 | 4.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 1.0 | 9.4 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 1.0 | 7.3 | GO:0046979 | TAP2 binding(GO:0046979) |
| 1.0 | 5.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 1.0 | 3.1 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
| 1.0 | 2.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 1.0 | 4.0 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 1.0 | 3.8 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.9 | 4.7 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
| 0.9 | 8.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.9 | 3.7 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.9 | 4.6 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 0.9 | 2.7 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
| 0.9 | 2.6 | GO:0004103 | choline kinase activity(GO:0004103) |
| 0.9 | 3.4 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.9 | 2.6 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
| 0.8 | 2.5 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 0.8 | 1.7 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
| 0.8 | 4.1 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.8 | 7.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.8 | 3.2 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.8 | 2.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.8 | 2.3 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 0.8 | 13.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.8 | 2.3 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
| 0.8 | 5.3 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.7 | 2.2 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.7 | 2.9 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.7 | 2.2 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.7 | 8.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.7 | 5.1 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.7 | 2.9 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.7 | 3.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.7 | 2.1 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
| 0.7 | 9.0 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
| 0.7 | 4.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.7 | 2.1 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.7 | 4.8 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.7 | 2.0 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 0.7 | 3.4 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.7 | 6.7 | GO:0005497 | androgen binding(GO:0005497) |
| 0.7 | 2.0 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
| 0.7 | 2.7 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.7 | 4.6 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.6 | 2.6 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 0.6 | 7.6 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.6 | 1.9 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 0.6 | 4.3 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.6 | 4.3 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.6 | 2.5 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 0.6 | 1.8 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
| 0.6 | 3.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.6 | 2.4 | GO:0005534 | galactose binding(GO:0005534) |
| 0.6 | 12.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.6 | 4.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.6 | 3.5 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.6 | 1.7 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.6 | 2.9 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.6 | 0.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.6 | 1.7 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.6 | 4.5 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 0.6 | 0.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.6 | 5.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.5 | 1.6 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
| 0.5 | 2.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.5 | 10.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.5 | 1.5 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 0.5 | 1.5 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.5 | 1.5 | GO:0016826 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
| 0.5 | 3.0 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.5 | 2.9 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
| 0.5 | 1.9 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
| 0.5 | 1.4 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
| 0.5 | 3.4 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.5 | 1.4 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.5 | 6.6 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.5 | 1.9 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.5 | 1.4 | GO:0016898 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
| 0.5 | 1.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.4 | 3.6 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.4 | 0.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.4 | 0.4 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 0.4 | 13.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.4 | 1.7 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
| 0.4 | 2.2 | GO:0010736 | serum response element binding(GO:0010736) |
| 0.4 | 2.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.4 | 2.2 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
| 0.4 | 1.7 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.4 | 2.5 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.4 | 1.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.4 | 2.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.4 | 9.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.4 | 3.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
| 0.4 | 13.5 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
| 0.4 | 1.6 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.4 | 1.2 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.4 | 2.4 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.4 | 0.8 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 0.4 | 25.3 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.4 | 10.3 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.4 | 5.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.4 | 3.9 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
| 0.4 | 14.6 | GO:0001848 | complement binding(GO:0001848) |
| 0.4 | 2.3 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 0.4 | 1.9 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 0.4 | 5.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.4 | 1.1 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.4 | 1.1 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.4 | 3.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.4 | 1.1 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.4 | 0.7 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 0.4 | 1.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.4 | 1.1 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 0.4 | 1.4 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.4 | 0.7 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) sulfate transmembrane transporter activity(GO:0015116) |
| 0.4 | 1.4 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.4 | 4.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.4 | 0.7 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.4 | 3.5 | GO:0019864 | IgG binding(GO:0019864) |
| 0.4 | 1.1 | GO:0008892 | guanine deaminase activity(GO:0008892) |
| 0.3 | 5.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.3 | 1.0 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.3 | 1.4 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.3 | 3.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.3 | 6.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.3 | 1.0 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.3 | 1.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.3 | 10.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.3 | 1.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.3 | 1.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.3 | 3.0 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.3 | 2.0 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.3 | 2.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.3 | 9.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.3 | 1.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.3 | 1.3 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
| 0.3 | 0.6 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.3 | 1.0 | GO:0047086 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) |
| 0.3 | 1.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.3 | 1.0 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 0.3 | 2.2 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
| 0.3 | 2.2 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.3 | 1.9 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.3 | 0.9 | GO:0047661 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.3 | 1.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.3 | 1.5 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 0.3 | 1.5 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.3 | 2.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.3 | 2.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.3 | 1.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.3 | 1.2 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.3 | 1.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.3 | 0.9 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
| 0.3 | 1.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.3 | 3.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.3 | 8.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.3 | 1.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.3 | 1.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.3 | 4.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.3 | 5.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.3 | 1.9 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.3 | 1.1 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.3 | 3.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.3 | 1.1 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.3 | 1.1 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 0.3 | 1.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.3 | 0.8 | GO:0070362 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
| 0.3 | 0.8 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.3 | 0.8 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
| 0.3 | 0.5 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.3 | 2.6 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 0.3 | 1.8 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 0.3 | 0.8 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.3 | 2.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.3 | 3.6 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.3 | 3.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.3 | 0.5 | GO:0004803 | transposase activity(GO:0004803) |
| 0.3 | 2.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.3 | 8.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.3 | 2.5 | GO:0016803 | ether hydrolase activity(GO:0016803) |
| 0.3 | 1.5 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.2 | 0.7 | GO:0008124 | phenylalanine 4-monooxygenase activity(GO:0004505) 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
| 0.2 | 1.5 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.2 | 0.2 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.2 | 1.2 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.2 | 0.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.2 | 9.6 | GO:0051183 | vitamin transporter activity(GO:0051183) |
| 0.2 | 1.9 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.2 | 0.7 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.2 | 3.8 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.2 | 4.7 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.2 | 0.5 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.2 | 0.2 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 0.2 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.2 | 0.5 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 0.2 | 1.6 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.2 | 4.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.2 | 0.2 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) copper-dependent protein binding(GO:0032767) |
| 0.2 | 0.7 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.2 | 6.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.2 | 0.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.2 | 1.6 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.2 | 0.2 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 0.2 | 1.6 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.2 | 2.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.2 | 2.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.2 | 0.7 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
| 0.2 | 2.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.2 | 0.9 | GO:0005019 | platelet-derived growth factor beta-receptor activity(GO:0005019) |
| 0.2 | 1.1 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.2 | 2.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.2 | 1.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.2 | 0.9 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 0.2 | 0.6 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.2 | 1.1 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 0.2 | 1.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.2 | 1.7 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.2 | 0.6 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.2 | 5.1 | GO:0031432 | titin binding(GO:0031432) |
| 0.2 | 0.6 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 0.2 | 1.9 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.2 | 1.7 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.2 | 0.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.2 | 4.6 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
| 0.2 | 0.6 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
| 0.2 | 3.7 | GO:0008430 | selenium binding(GO:0008430) |
| 0.2 | 0.4 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.2 | 0.8 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.2 | 4.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.2 | 6.5 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.2 | 3.9 | GO:0070513 | death domain binding(GO:0070513) |
| 0.2 | 1.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.2 | 1.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.2 | 0.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.2 | 1.0 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.2 | 6.6 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
| 0.2 | 0.8 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.2 | 3.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.2 | 0.4 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.2 | 1.0 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
| 0.2 | 0.6 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
| 0.2 | 2.3 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.2 | 3.1 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.2 | 2.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.2 | 1.4 | GO:0042806 | fucose binding(GO:0042806) |
| 0.2 | 2.1 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.2 | 0.6 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
| 0.2 | 1.0 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 0.2 | 2.1 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.2 | 2.7 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.2 | 0.6 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.2 | 2.7 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.2 | 4.4 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.2 | 2.3 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
| 0.2 | 2.7 | GO:0089720 | caspase binding(GO:0089720) |
| 0.2 | 46.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.2 | 0.9 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.2 | 0.6 | GO:0005427 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
| 0.2 | 2.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.2 | 1.3 | GO:0048038 | quinone binding(GO:0048038) ubiquinone binding(GO:0048039) |
| 0.2 | 1.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.2 | 2.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.2 | 1.6 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.2 | 0.5 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.2 | 0.7 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
| 0.2 | 0.7 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.2 | 3.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
| 0.2 | 1.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.2 | 0.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.2 | 0.5 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
| 0.2 | 1.4 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.2 | 7.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.2 | 2.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.2 | 2.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.2 | 0.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.2 | 3.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.2 | 0.9 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
| 0.2 | 1.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.2 | 4.0 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.2 | 1.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.2 | 3.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.2 | 2.9 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
| 0.2 | 2.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.2 | 1.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.2 | 5.9 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.2 | 0.5 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.2 | 2.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.2 | 9.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.2 | 2.7 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.2 | 1.2 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.2 | 0.7 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.2 | 0.5 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
| 0.2 | 0.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
| 0.2 | 0.5 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.2 | 3.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.2 | 1.8 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.2 | 0.8 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
| 0.2 | 0.6 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 0.2 | 4.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.2 | 1.4 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.2 | 0.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.2 | 0.8 | GO:0002046 | opsin binding(GO:0002046) |
| 0.2 | 0.9 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.2 | 1.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.2 | 0.5 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
| 0.2 | 0.6 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.2 | 0.6 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.2 | 2.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.2 | 0.8 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.2 | 1.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.2 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.1 | 0.7 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.1 | 0.7 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
| 0.1 | 1.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.1 | 1.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.1 | 1.6 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
| 0.1 | 1.0 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.1 | 0.6 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.1 | 0.7 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.1 | 0.1 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
| 0.1 | 0.6 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 0.1 | 3.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.1 | 0.4 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.1 | 1.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.1 | 4.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.1 | 2.9 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.1 | 0.9 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 0.1 | 2.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.1 | 0.4 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.1 | 18.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 0.4 | GO:0035643 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
| 0.1 | 3.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.1 | 0.3 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.1 | 0.3 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
| 0.1 | 0.4 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.1 | 1.2 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.1 | 1.4 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.1 | 0.7 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.1 | 2.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.1 | 1.4 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.1 | 2.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.1 | 3.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.1 | 0.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.1 | 7.6 | GO:0061135 | endopeptidase inhibitor activity(GO:0004866) endopeptidase regulator activity(GO:0061135) |
| 0.1 | 1.8 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.1 | 0.5 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.1 | 0.3 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.1 | 7.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.1 | 2.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.1 | 1.7 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.1 | 4.0 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.1 | 0.7 | GO:0004556 | alpha-amylase activity(GO:0004556) |
| 0.1 | 0.4 | GO:0047536 | 2-aminoadipate transaminase activity(GO:0047536) |
| 0.1 | 1.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.1 | 0.4 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
| 0.1 | 0.6 | GO:0019144 | ADP-sugar diphosphatase activity(GO:0019144) |
| 0.1 | 1.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 13.6 | GO:0005179 | hormone activity(GO:0005179) |
| 0.1 | 3.9 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.1 | 0.4 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.1 | 0.5 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.1 | 2.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.1 | 0.9 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.1 | 0.4 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.1 | 0.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.1 | 1.0 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.1 | 0.1 | GO:0034617 | nitric-oxide synthase activity(GO:0004517) tetrahydrobiopterin binding(GO:0034617) |
| 0.1 | 0.6 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 0.1 | 2.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.1 | 0.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 10.0 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.1 | 0.6 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.1 | 2.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.1 | 0.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.1 | 0.3 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.1 | 4.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 0.3 | GO:0042007 | interleukin-18 binding(GO:0042007) |
| 0.1 | 0.8 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.1 | 0.2 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 0.1 | 3.8 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
| 0.1 | 0.7 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.1 | 1.0 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.1 | 2.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.1 | 0.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.1 | 0.9 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.1 | 1.3 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.1 | 0.6 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.1 | 0.9 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.1 | 4.2 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
| 0.1 | 1.0 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.1 | 0.7 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
| 0.1 | 0.7 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.1 | 4.6 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 1.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.1 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
| 0.1 | 0.6 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.1 | 1.6 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.1 | 1.1 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.1 | 0.6 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.1 | 3.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.1 | 0.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.1 | 0.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.1 | 3.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 0.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.1 | 3.9 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
| 0.1 | 0.3 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.1 | 0.2 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
| 0.1 | 0.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.1 | 0.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.1 | 0.5 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.1 | 1.9 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.1 | 0.7 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.1 | 0.3 | GO:0047291 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
| 0.1 | 0.2 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
| 0.1 | 0.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
| 0.1 | 1.8 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.1 | 0.4 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.1 | 2.9 | GO:0015297 | antiporter activity(GO:0015297) |
| 0.1 | 0.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.1 | 1.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.1 | 0.4 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
| 0.1 | 0.2 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.1 | 0.8 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.1 | 0.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.1 | 10.5 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.1 | 0.8 | GO:0019865 | immunoglobulin binding(GO:0019865) |
| 0.1 | 0.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 0.1 | 1.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.1 | 0.3 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 0.1 | 0.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.1 | 1.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.1 | 2.2 | GO:0005272 | sodium channel activity(GO:0005272) |
| 0.1 | 0.5 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.1 | 0.5 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.1 | 0.3 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
| 0.1 | 0.9 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.1 | 0.5 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.1 | 0.6 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
| 0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.1 | 0.3 | GO:0050577 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
| 0.1 | 1.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
| 0.1 | 0.8 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 0.1 | 2.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 0.4 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
| 0.1 | 4.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.1 | 0.7 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.1 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.1 | 23.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 2.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.1 | 0.3 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.1 | 0.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.1 | 0.6 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.1 | 1.0 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.1 | 0.6 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.1 | 0.7 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.1 | 0.5 | GO:0052843 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.1 | 0.2 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 0.1 | 0.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.1 | 1.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.1 | 2.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.1 | 6.5 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.1 | 0.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.1 | 2.3 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.1 | 0.6 | GO:0019841 | retinol binding(GO:0019841) |
| 0.1 | 0.2 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 0.1 | 0.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.1 | 11.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.1 | 0.6 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.1 | 0.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.1 | 0.1 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
| 0.1 | 1.3 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.1 | 0.7 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.1 | 0.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.1 | 5.6 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
| 0.1 | 0.2 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.1 | 0.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.1 | 0.4 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.1 | 0.2 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
| 0.1 | 0.3 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.1 | 0.3 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.1 | 0.2 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.1 | 0.5 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 0.1 | 0.1 | GO:0002060 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
| 0.1 | 0.2 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.1 | 0.4 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.1 | 0.1 | GO:0046977 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
| 0.1 | 0.5 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 0.1 | 1.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.1 | 0.5 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.1 | 1.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.1 | 0.2 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.1 | 0.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.1 | 2.3 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.1 | 0.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.1 | 0.5 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.1 | 0.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.1 | 0.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.1 | 0.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.1 | 0.3 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.1 | 0.4 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.1 | 0.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
| 0.1 | 0.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.1 | 0.4 | GO:0035877 | death effector domain binding(GO:0035877) cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 0.1 | 0.1 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
| 0.1 | 0.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.1 | 0.2 | GO:0032093 | SAM domain binding(GO:0032093) |
| 0.1 | 1.1 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.1 | 0.1 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
| 0.1 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.1 | 0.2 | GO:0048030 | disaccharide binding(GO:0048030) |
| 0.1 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.1 | 0.2 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.1 | 0.2 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 0.1 | 0.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.1 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 0.1 | 0.5 | GO:0015250 | water channel activity(GO:0015250) |
| 0.1 | 1.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.1 | 0.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.1 | 0.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.1 | 11.2 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.1 | 0.1 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.1 | 0.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.1 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.1 | 0.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.1 | 0.3 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.1 | 0.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.1 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.1 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.1 | 0.3 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
| 0.1 | 0.2 | GO:0016731 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
| 0.1 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.1 | 0.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 0.8 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.1 | 0.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.1 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 0.1 | 0.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
| 0.0 | 0.6 | GO:0099589 | serotonin receptor activity(GO:0099589) |
| 0.0 | 0.1 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.0 | 0.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.0 | 0.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.0 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.0 | 0.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.0 | 0.2 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
| 0.0 | 0.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.0 | 0.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| 0.0 | 0.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.0 | 0.2 | GO:0035240 | dopamine binding(GO:0035240) |
| 0.0 | 0.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.0 | 0.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.0 | 0.2 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
| 0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.0 | 17.2 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.0 | 0.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.0 | 0.2 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.0 | 0.4 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.0 | 1.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.0 | 0.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.0 | 0.1 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.0 | 0.8 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 0.0 | 0.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.0 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.0 | 0.1 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.0 | 0.3 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.0 | 2.0 | GO:0070888 | E-box binding(GO:0070888) |
| 0.0 | 0.3 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.0 | 0.2 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.0 | 0.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
| 0.0 | 0.1 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
| 0.0 | 0.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.0 | 0.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.0 | 0.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.0 | 0.6 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.0 | 0.4 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.0 | 0.2 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.0 | 0.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
| 0.0 | 0.4 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
| 0.0 | 0.4 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.0 | 0.2 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
| 0.0 | 0.2 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
| 0.0 | 0.3 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.0 | 0.1 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.0 | 0.1 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.0 | 14.8 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
| 0.0 | 1.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.0 | 0.3 | GO:0016594 | glycine binding(GO:0016594) |
| 0.0 | 0.2 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
| 0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.0 | 1.0 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.0 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.0 | 0.4 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.0 | 1.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.0 | 0.1 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
| 0.0 | 0.1 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.0 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.0 | 1.3 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.0 | 0.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.0 | 0.2 | GO:0015197 | peptide transporter activity(GO:0015197) |
| 0.0 | 0.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.0 | 0.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.0 | 0.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.0 | 1.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.0 | 0.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.0 | 0.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.0 | 1.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.0 | 1.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.0 | 0.1 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
| 0.0 | 0.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.0 | 0.3 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
| 0.0 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.0 | 0.1 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.0 | 0.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.0 | 0.1 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
| 0.0 | 2.9 | GO:0008201 | heparin binding(GO:0008201) |
| 0.0 | 0.1 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.0 | 0.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.0 | 0.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.0 | 0.1 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 0.0 | 5.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 4.2 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.0 | 1.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.0 | 0.1 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
| 0.0 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.0 | 0.3 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
| 0.0 | 0.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.0 | 0.3 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.0 | 0.2 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
| 0.0 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.0 | 0.2 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.0 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.0 | 0.7 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.0 | 0.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.0 | 0.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.0 | 0.1 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.0 | 0.1 | GO:0015067 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
| 0.0 | 0.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.0 | 0.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.0 | 0.3 | GO:0046332 | SMAD binding(GO:0046332) |
| 0.0 | 0.4 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
| 0.0 | 1.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.0 | 0.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.0 | 0.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.0 | 0.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.0 | 0.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.0 | 0.1 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.0 | 0.3 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
| 0.0 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.0 | 0.1 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 0.0 | 0.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.0 | 0.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
| 0.0 | 0.1 | GO:1902444 | riboflavin binding(GO:1902444) |
| 0.0 | 0.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.0 | 0.2 | GO:0001159 | core promoter proximal region DNA binding(GO:0001159) |
| 0.0 | 0.2 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.0 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.0 | 0.7 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
| 0.0 | 0.1 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
| 0.0 | 0.0 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
| 0.0 | 0.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 0.0 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.0 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.0 | 0.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.0 | 0.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.0 | 0.0 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
| 0.0 | 0.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.0 | 0.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 1.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.4 | 1.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.4 | 5.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.4 | 3.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.4 | 24.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.3 | 14.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.3 | 0.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.3 | 9.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.3 | 3.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.2 | 0.5 | PID EPO PATHWAY | EPO signaling pathway |
| 0.2 | 2.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.2 | 8.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.2 | 17.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.2 | 8.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.2 | 0.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.2 | 7.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.2 | 8.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.2 | 15.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.2 | 0.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.2 | 0.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.2 | 3.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.1 | 0.4 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.1 | 4.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.1 | 5.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.1 | 6.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.1 | 1.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.1 | 2.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 1.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.1 | 8.5 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.1 | 51.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.1 | 5.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.1 | 6.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 1.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 1.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 3.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.1 | 0.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 0.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.1 | 25.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 2.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.1 | 0.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.1 | 0.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.1 | 0.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.1 | 1.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.1 | 0.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.1 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.1 | 0.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.1 | 0.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.1 | 0.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.1 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.1 | 1.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 0.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 1.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.1 | 17.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 3.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 3.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.0 | 2.7 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.0 | 1.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 0.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.0 | 1.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 10.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.0 | 1.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.0 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.0 | 1.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.0 | 0.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.0 | 1.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.0 | 0.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.0 | 1.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.0 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.0 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.0 | 2.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.0 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.0 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.0 | 0.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
| 0.0 | 0.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.0 | 0.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.5 | 34.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 1.0 | 9.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.6 | 2.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.5 | 12.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.5 | 49.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.5 | 0.5 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.5 | 46.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.4 | 11.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.4 | 13.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.4 | 12.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.4 | 5.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.4 | 26.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.4 | 3.5 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.4 | 18.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.4 | 11.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.4 | 6.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.4 | 6.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.4 | 3.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.4 | 5.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.3 | 9.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.3 | 4.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.3 | 8.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.3 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.3 | 6.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.3 | 1.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.2 | 7.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.2 | 5.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.2 | 7.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.2 | 3.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.2 | 12.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.2 | 5.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.2 | 34.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.2 | 13.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.2 | 15.5 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.2 | 3.0 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.2 | 2.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.2 | 0.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.2 | 25.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.2 | 12.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.2 | 10.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.2 | 4.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.2 | 3.4 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.2 | 4.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.2 | 1.5 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
| 0.2 | 2.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.2 | 0.7 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
| 0.2 | 2.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.2 | 11.6 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.2 | 1.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.1 | 1.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.1 | 8.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 0.6 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.1 | 3.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 1.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.1 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.1 | 1.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 0.9 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
| 0.1 | 1.5 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.1 | 0.9 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
| 0.1 | 9.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.1 | 3.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.1 | 13.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 16.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.1 | 5.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.1 | 2.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 3.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 1.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 1.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.1 | 5.1 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
| 0.1 | 0.3 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 0.1 | 6.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.1 | 14.5 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.1 | 1.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.1 | 0.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.1 | 1.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.1 | 2.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.1 | 0.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.1 | 2.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 1.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.1 | 0.5 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.1 | 7.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.1 | 6.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.1 | 2.9 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.1 | 1.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.1 | 0.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.1 | 1.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.1 | 5.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.1 | 3.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.1 | 1.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.1 | 8.9 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 0.1 | 1.7 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.1 | 2.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
| 0.1 | 1.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 1.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.1 | 1.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 1.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.1 | 1.8 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.1 | 1.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.1 | 0.9 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.1 | 1.9 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
| 0.1 | 0.9 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.1 | 1.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.1 | 1.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.1 | 0.5 | REACTOME OPSINS | Genes involved in Opsins |
| 0.1 | 0.9 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.1 | 0.6 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.1 | 1.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.1 | 2.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.0 | 1.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.0 | 0.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.0 | 0.7 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.0 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.0 | 0.5 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
| 0.0 | 0.5 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
| 0.0 | 0.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.0 | 0.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.0 | 0.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.0 | 0.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.0 | 0.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.0 | 1.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.0 | 0.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.0 | 1.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.0 | 0.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 2.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.0 | 0.5 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
| 0.0 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.0 | 0.0 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
| 0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.0 | 0.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.0 | 1.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.0 | 0.7 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
| 0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.0 | 1.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |